Transient transcriptome sequencing captures enhancer landscapes immediately after T-cell stimulation by Demel, Carina
Dissertation zur Erlangung des Doktorgrades
der Fakultät für Chemie und Pharmazie
der Ludwig-Maximilians-Universität München
Transient transcriptome sequencing
captures enhancer landscapes
immediately after T-cell stimulation
Carina Elke Demel
aus
München, Deutschland
2017

Erklärung
Diese Dissertation wurde im Sinne von § 7 der Promotionsordnung vom
28.November 2011 von Herrn Prof. Dr. Patrick Cramer betreut.
Eidesstattliche Versicherung
Diese Dissertation wurde eigenständig und ohne unerlaubte Hilfe erarbeitet.
München, den 30.03.2017
Carina Elke Demel
Dissertation eingereicht am: 03.04.2017
1. Gutachter: Prof. Dr. Patrick Cramer
2. Gutachter: PD Dr. Dietmar Martin
Mündliche Prüfung am: 29.05.2017

Acknowledgements
I am truly grateful to Prof. Dr. Patrick Cramer for giving me the opportunity
to work in his lab, for his supervision and guidance on this fascinating project. I
appreciate his positive attitude despite high workload and I am thankful for all
the encouraging and supportive discussions. It has been a pleasure to work in this
outstanding scientific environment.
I would like to express my deepest gratitude to Prof. Dr. Julien Gagneur, from
whom I have learned a lot. I am deeply grateful for his help on mathematical and
statistical methods that became a substantial part of this thesis. He always had
great ideas and gave very valueable input on data analysis and the manuscript.
Special thanks goes to Prof. Dr. Achim Tresch, who introduced me to the field of
systems biology and offered me a collaborative project with Patrick Cramer, thereby
paving the way for my future.
I would like to thank the other members of my thesis committee: PD Dr. Dietmar
Martin, Dr. Fabiana Perocchi, and Prof. Dr. Förstemann for their time and support.
Moreover, I want to especially thank Margaux Michel, who generated all the
high-quality data that formed the basis of my work. Together we have learned a lot
about sequening protocols, biases, and quality control. I am really happy I could
work with such a great biochemist and wonderful person, and I am happy to see
that all our efforts turned into a nice manuscript.
Likewise, I am deeply grateful to Björn Schwalb, who shared the office, ideas,
and code with me for more than 8 years now. It has been a pleasure to work with
him.
Furthermore, I am particularly grateful to Benedikt Zacher, Katja Frühauf,
Michael Lidschreiber, Philipp Eser, Leonhard Wachutka, Kerstin Maier, Ania Saw-
icka, and Katharina Hofmann, for fruitful scientific discussions and collaborations.
I owe my gratitute to all present and former members of the Cramer, Gagneur,
Tresch, and Söding labs, for the extraordinary working atmosphere that made me
enjoy coming to work every single day. I am happy that I can count many of my
collegues to my friends and want to thank Margaux, Björn, Merle, Michi, Katja,
Saskia, Sofia, Wolfgang, Katharina, Ania, Jinmi, Livia, and Kristina for fun times
v
outside the lab and especially our weekend trips to Stockholm, Hannover, Krakow,
Bremen, Barcelona, Berlin, Hamburg, Goslar, and Cologne. Special thanks goes to
the Gagneur lab and the remaining Söding lab for hosting me every time I came to
Munich. I always felt warmly welcomed and I am happy to count many of them to
my friends. I also want to thank my graduate school QBM for the financial support,
interesting workshops, and social activities. In this context, I would like to extend
my thanks to all the people who helped me in bureaucratic issues and kept the labs
running both at the Gene Center in Munich and at the MPI in Göttingen.
Many thanks to Verena Link, Marco Leitwein, Katharina Hofmann, Thomas
Demel, and Björn Schwalb for critical reading (parts) of this thesis.
I am very grateful to Marco, who supports me in everything I do and makes my
life better, easier, and funnier.
Last but not least, I want to thank my whole family. They were always interested
in my work and its progress. Above all, I am grateful to my parents for their
continuous support, unconditional love, and always believing in me.
vi
Summary
Transcription regulation is poorly understood. Transcriptional enhancers produce
enhancer RNAs (eRNAs), a class of transient RNAs, whose function remains mainly
unclear.
To monitor transcriptional regulation in human cells, rapid changes in enhancer
and promoter activity must be captured with high sensitivity and temporal reso-
lution. Here I show that the recently established protocol TT-seq (‘transient tran-
scriptome sequencing’) can monitor rapid changes in transcription from enhancers
and promoters during the immediate response of T-cells to ionomycin and phorbol
12-myristate 13-acetate (PMA). Transient transcriptome sequencing (TT-seq) maps
eRNAs and mRNAs every 5 minutes after T-cell stimulation with high sensitivity,
and identifies many new primary response genes. TT-seq reveals that the synthesis
of 1,601 eRNAs and 650 mRNAs changes significantly within only 15 minutes after
stimulation, when standard RNA-seq does not detect differentially expressed genes.
Transcription of enhancers that are primed for activation by nucleosome depletion
can occur immediately and simultaneously with transcription of target gene promot-
ers. My results indicate that enhancer transcription is a good proxy for enhancer
regulatory activity in target gene activation, and establish TT-seq as a tool for
monitoring the dynamics of enhancer landscapes and transcription programs during
cellular responses and differentiation.
Additionally, I developed a normalization method for TT-seq that scales labeled
and total RNA-seq samples relative to each other, allowing to determine absolute
half-lives. The method provides a powerful tool to normalize various samples relative
to each other on a global scale, and therefore allows to observe global changes in
RNA synthesis and degradation.
Taken together, metabolical labeling of RNA followed by kinetic modeling en-
ables to quantify RNA metabolism rates and to detect dynamic changes in enhancer
landscapes and RNA expression levels.
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Part I
Introduction
Parts of this section have been published in:
TT-seq captures enhancer landscapes immediately after T-cell stimulation
M. Michel*, C. Demel*, B. Zacher, B. Schwalb, S. Krebs, H. Blum, J. Gagneur, and P. Cramer
Molecular Systems Biology (2017)
For detailed author contributions see page ix.
The central dogma of molecular biology postulated by Francis Crick (Crick 1970)
explains the transfer of genetic information among the three classes of biopolymers:
the deoxyribonucleic acid (DNA), the ribonucleic acid (RNA) and proteins. DNA
encodes the genetic information that gets replicated during cell division (replica-
tion). DNA is transcribed into RNA (transcription), which serves as template for
protein synthesis by ribosomes during translation.
During transcription the genetic information encoded in the DNA is transcribed
into RNA by DNA-dependent RNA polymerases (Roeder et al. 1969). Eukaryotes
have three nuclear RNA polymerases (Pols): Pol I, Pol II and Pol III (Cramer et al.
2008). The three RNA polymerases synthesize different classes of transcripts: Pol I
produces most of the ribosomal RNAs (rRNAs), Pol II is responsible for the synthesis
of messenger RNAs (mRNAs) and several classes of non-coding RNAs (ncRNAs),
such as small nucleolar RNAs (snoRNAs), small nuclear RNAs (snRNAs), long non-
coding RNAs (lncRNAs), and enhancer RNAs (eRNAs), and Pol III synthesizes
transfer RNAs (tRNAs), 5s rRNA, and other small RNAs (Cramer et al. 2008).
Transcription is a highly studied process (Section 1). The complexity of eu-
rkaryotic transcriptomes is not only created by the genome size and the number of
transcripts and transcript isoforms, but also by highly dynamic transcription regula-
tion mechanisms. In eukaryotes, the spatio-temporal patterns of gene expression are
established by enhancers (Section 2). Proper regulation of transcription is required
for development, growth, cellular differentiation, and responses to environmental
stimuli. One well-studied model system for the response to a stimulus is T-cell
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activation (Section 3).
In recent years, high-resolution methods such as deep-sequencing of RNA (RNA-
seq and its derivatives) or chromatin-immunoprecipitated samples (ChIP-seq) have
been developed (Johnson et al. 2007; Wang et al. 2009b). The direct sequencing
of transcription products or regions of active transcription marked by specific tran-
scription factors led to improved transcriptome profiling, as these methods are not
restricted to known transcript annotations (Mortazavi et al. 2008; Nagalakshmi et
al. 2008) (Section 4). The development of these high-resolution profiling methods
revealed that the majority of the genome is pervasively transcribed (Djebali et al.
2012; Jacquier 2009). This resulted in the identification of new transcript classes,
such as eRNAs, which are short, usually unstable transcripts originating from en-
hancer sequences (Kim et al. 2010; Ren 2010; Wang et al. 2011). The function of
eRNAs is not completely understood, but it is possible they influence transcription
regulation (Section 2).
The combination of metabolic RNA labeling (Section 4.2) and RNA-sequencing
creates new challenges for sample normalization (Section 5), but also presents new
opportunities to model RNA synthesis and degradation rates (Section 6).
1 Transcription by RNA Polymerase II
In eukaryotes, RNA polymerase II (Pol II) transcribes protein-coding genes into
mRNAs as well as several classes of non-coding RNAs (Cramer et al. 2008). The syn-
thesis of mRNAs is completed in a cyclic process that can be divided into three major
steps: initiation and promoter clearance (Section 1.1), elongation (Section 1.2), and
termination (Section 1.3). Transcription is tightly coupled with mRNA processing
to ensure the maturation of mRNA precursors (pre-mRNA). Correctly transcribed
and processed RNAs are exported into the cytoplasm, where they get translated
into proteins by ribosomes.
Figure 1 shows an overview of the transcription cycle of protein-coding genes,
which is explained in detail below.
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Figure 1: Schematic representation of the eukaryotic transcription process. Adapted from
(Shandilya et al. 2012; Parker et al. 2007; Svejstrup 2004).
1.1 Transcription initiation and promoter clearance
The first crucial step of transcription initiation is the formation of the transcription-
competent pre-initiation complex (PIC) on the promoter sequence. DNA is wrapped
around nucleosomes, and therefore not accessible for the transcription machinery.
Chromatin remodellers and histone modifying enzymes are required for transcription
initiation, as they provide access for the transcription machinery to the template
DNA (Li et al. 2007; Svejstrup 2004).
The PIC contains the general transcription factors (GTFs) TFIIA, -B, -D, -E,
-F, and -H, and Pol II. PIC assembly starts by TFIID binding to defined promoter
elements. At TATA-containing promoters, the TATA-binding protein (TBP) and
TBP associated factors (TAFs) recognize the TATAA sequence (Buratowski et al.
1989; Buratowski 1994). The majority of eurkaryotic promoters lacks a canonical
TATA box and other core promoter elements (CPEs), such as the initiator (Inr) and
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downstream promoter elements (DPE), act as promoter recognition elements for the
transcription machinery (Shandilya et al. 2012). TBP associates with co-activator
complexes such as TFIID or SAGA (Basehoar et al. 2004). After TFIID binding,
the other GTFs and Pol II are either recruited sequentially (Buratowski et al. 1989)
or in the form of a pre-assembled holoenzyme to the promoter sequence to form the
PIC (Koleske et al. 1994). The co-activator Mediator, which is recruited by tran-
scriptional activators bound to upstream activating sequences (UASs), promotes PIC
formation by facilitating the recruitment of Pol II to the emerging PIC (Kornberg
2005; Malik et al. 2005).
ATP-dependent promoter melting around the gene’s transcription start site (TSS)
allows the open complex formation by the helicase activity of TFIIH (Hahn 2004;
Wang et al. 1992). This step, also called PIC activation, provides access for Pol II
to the template strand via the transcription ‘bubble’ and allows the formation of
the first phosphodiester bond (Roeder 1996; Wang et al. 1992). The beginning
synthesis of RNA often results in the release of short (2-3 nt) abortive transcripts
while Pol II is still associated with the promoter (Margeat et al. 2006). The growing
nascent RNA increases the stability of the transcription complex and results in pro-
moter clearance (Kugel et al. 2002). When the nascent transcript reaches a length
of 8-9 nt, the RNA:DNA hybrid is thermodynamically stable, elongation continues
and the likelihood of premature RNA release is reduced (Roeder 1996; Sidorenkov
et al. 1998). TFIID, TFIIA, TFIIB, and the Mediator complex dissociate from the
transcription machinery and stay attached to the promoter, allowing for a rapid
reinitiation of Pol II (Section 1.3).
1.2 Transcription elongation
The transition from initiation to early elongation is accompanied by a conforma-
tional change of Pol II (Proudfoot et al. 2002). The Pol II C-terminal domain
(CTD) consists of multiple YSPTSPS heptapeptide repeats (26 in yeast, 52 in mam-
mals) (Corden et al. 1985), which serve as binding platform for RNA maturation
factors that process RNA co-transcriptionally (Hirose et al. 2000; McCracken et al.
1997b). Except for proline (P), all amino acids of the CTD can be phosphorylated
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and the CTD phosphoylation status changes dynamically during the transcription
cycle (‘CTD code’) (Buratowski 2003; Hahn 2004; Nechaev et al. 2011; Proudfoot et
al. 2002) and stimulates the pre-mRNA processing steps (Fong et al. 2001). During
promoter binding, the CTD is mostly unphosphorylated and attracts factors such
as Mediator that stabilize the PIC (Myers et al. 1998). Phosphorylation of the CTD
at Serine-5 residues by the TFIIH subunit CDK7 destabilizes these interactions and
favors promoter escape and therefore promotes the transition from initiation into
early elongation (Liu et al. 2004).
Serine-5 phosphorylation (S5P) is also recognized by capping enzymes (Cho et al.
1997; McCracken et al. 1997a). When the nascent RNA reaches a length of 20-30 nt,
a 7-methyl-guanosine cap is added to its 5’ end (Rasmussen et al. 1993). Capping is
important for RNA stability, nuclear export, and enhances translation (Proudfoot
et al. 2002).
Transcription can be regulated during early elongation by promoter-proximal
pausing (PPP) of Pol II (Core et al. 2008). The DRB-sensitivity inducing fac-
tor (DSIF) and the negative elongation factor (NELF) act as negative elongation
factors on Pol II (Renner et al. 2001). The positive elongation factor P-TEFb
phosphorylates DSIF and NELF, phosphorylated NELF is released, and DSIF acts
as positive elongation factor (EF) on Pol II and transcription enters productive
elongation (Marshall et al. 1995). The cyclin-dependent kinase CDK9, a subunit
of P-TEFb, is responsible for increasing phosphorylatation of CTD Serine-2 (S2P)
towards the 3’ end of the gene (Marshall et al. 1995; Peterlin et al. 2006), while
Serine-5 is gradually dephosphorylated by Ssu72 (Reyes-Reyes et al. 2007). The
elevated levels of Serine-2 phosphorylation increase the affinity for the recruitment
of the splicing complex, which performs co-transcriptional splicing on the nascent
pre-mRNA (Ardehali et al. 2009).
1.3 Transcription termination and reinitiation
Hyper-phosphorylation of CTD at Serine-2 residues plays a key role in termination,
as it recruits 3’ end processing factors, such as the cleavage and polyadenylation
specificity factor (CPSF) and the cleavage stimulatory factor (CstF), to the poly-
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merase (Ahn et al. 2004; McCracken et al. 1997b). For eukaryotic protein-coding
genes, 3’ end processing and transcription termination are tightly coupled (Whitelaw
et al. 1986). Once the polymerase transcribes the polyadenylation (pA) signal, a
highly conserved AATAAA sequence followed by a G/T-rich downstream sequence
element (DSE) (Colgan et al. 1997; Proudfoot et al. 2002; Zhao et al. 1999), CPSF
and CstF recognize these sequence elements in the emerging transcript, promote
pausing of Pol II, and induce cleavage of the nascent transcript directly after the
pA site so that it gets released from Pol II (Gilmartin et al. 1989). Poly(A) poly-
merase (PAP) is recruited to the termination machinery and adds the poly(A) tail to
the newly generated 3’ end (Colgan et al. 1997; Moore et al. 1985). Polyadenylation
is required for export to the cytoplasm (Huang et al. 1996), where translation takes
place.
Transcription termination downstream the pA site can be explained by two dif-
ferent models. In the ‘anti-termination’ model, Pol II stays associated with the DNA
until elongation factors (antiterminator factors) dissociate from the complex at the
pA site (Logan et al. 1987; Proudfoot 2004). In the ‘torpedo’ model Pol II stays
associated with the DNA and continues transcribing downstream the pA site (Con-
nelly et al. 1988; Proudfoot 1989). The newly formed 5’ end of the polymerase-
associated RNA is uncapped and unprotected and is therefore attacked by the RNA
5’ to 3’ exonuclease Xrn2 for nucleolytic degradation. When Xrn2 catches up with
Pol II, transcription terminates and Pol II is displaced from the DNA (Kim et al.
2004; Teixeira et al. 2004; West et al. 2004).
The released hypo-phosphorylated Pol II can enter a new round of transcription.
Gene looping (Ansari et al. 2005) and the promoter-bound GTFs that form a ‘reini-
tiation scaffold’ (Yudkovsky et al. 2000) facilitate efficient recycling and reinitiation
of Pol II on the same template (Dieci et al. 1996).
2 Regulation of transcription by enhancers
In metazoan cells, the synthesis of mRNAs from protein-coding genes during tran-
scription is driven from promoters and activated by enhancers (Lenhard et al. 2012;
Levine et al. 2014). Enhancers are regulatory units in the genome that contain
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binding sites for sequence-specific transcription factors and can activate mRNA tran-
scription over long distances (Banerji et al. 1981) (Section 2.1). Active enhancers
adopt an open chromatin structure (Calo et al. 2013) and recruit co-activators such
as Mediator (Fan et al. 2006). Mediator can apparently bridge between enhancers
and promoters because it binds both transcriptional activators and the Pol II ini-
tiation complex at the promoter (Figure 2) (Liu et al. 2013; Malik et al. 2010).
Promoter-enhancer interaction (‘pairing’) increases initiation complex stability and
promotes Pol II escape from the promoter (Allen et al. 2015; DeMare et al. 2013;
Splinter et al. 2006). Promoter-enhancer pairing requires DNA looping that is facili-
tated within insulated neighborhoods, which are genomic regions formed by looping
of DNA between two CTCF-binding sites co-occupied by cohesin (Dowen et al. 2014;
Hnisz et al. 2016a; Phillips-Cremins et al. 2013) (Section 2.2).
The genome-wide identification of enhancers is crucial for studying cellular regu-
lation and differentiation, but remains technically challenging (Shlyueva et al. 2014).
Enhancers may be distinguished from other genomic regions through a signature
of histone modifications that can be mapped by chromatin immunoprecipitation
(ChIP) (Heintzman et al. 2007; Schübeler 2007; Visel et al. 2009) or DNA accessi-
bility assays (Shlyueva et al. 2014; Thurman et al. 2012; Xi et al. 2007). Regulatory
active enhancers may be identified through their transcriptional activity, which is
thought to be a good proxy for their function in promoter activation (Li et al. 2016;
Melgar et al. 2011; Wu et al. 2014). Transcribed enhancers produce eRNAs (Dje-
bali et al. 2012; Kim et al. 2010), which are difficult to detect because they are
short-lived (Rabani et al. 2014; Schwalb et al. 2016), rapidly degraded by the exo-
some (Lubas et al. 2015), and generally not conserved over species (Andersson et al.
2014) (Section 2.3).
2.1 Enhancer characteristics and identification
Enhancers are cis-regulatory elements in the genome that were first discovered in
the 1980s (Banerji et al. 1981; Maniatis et al. 1987; Orkin 1990). They can activate
or alleviate the gene expression of nearby promoters (Banerji et al. 1981). This
is achieved by binding of cell type-specific transcription factors to specific binding
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sites in the enhancer sequence and delivering them to the transcription machinery
at the promoter via DNA looping (Section 2.2). The function of enhancers is highly
cell type and cell context-dependent. Different enhancer elements may regulate the
same promoter under different conditions (Chan et al. 2010). Enhancers can act over
long-range distances up to several megabases and independently of their orientation
relative to their target genes (Banerji et al. 1981; Maniatis et al. 1987).
The transcription factor-binding nature of enhancers can be used to identify
them via ChIP-seq. Especially the transcriptional coactivators CBP and p300 that
interact with the transcription machinery and acetylate histone tails at enhancers
to generate an open chromatin structure, have commonly been used to identify en-
hancers (Visel et al. 2009). ChIP-seq of characteristic histone modifications, such as
acetylation of H3 lysine 27 (H3K27ac) by CBP (Tie et al. 2009) or distinct methy-
lation patterns of H3K4, can also be used to identify enhancer elements. Enhancer
sequences show high levels of H3K4 mono- and di-methylation (H3K4me1/2) and
at the same time low levels of H3K4me3. As promoter sequences show the oppo-
site pattern, the ratio H3K4me3/H3K4me1 is often used to distinguish enhancers
from promoters (Heintzman et al. 2007). Additionally, the open chromatin struc-
ture at enhancers that allows binding of transcription factors (TFs) is related to
DNase I hypersensitivity (Schaffner 2015), which can be identified by DNase-seq or
ATAC-seq.
2.2 Chromatin looping and promoter-enhancer interactions
Chromatin is usually organized in compartments that are in close spatial proximity,
called topologically associated domains (TADs) (Figure 2), which are separated from
each other by the insulator protein CCCTC-binding factor (CTCF) and cohesin
binding at TAD boundaries (Dixon et al. 2012; Gonzalez-Sandoval et al. 2016). The
frequency of long-range DNA interactions is higher inside TADs than between TADs,
therefore TADs are constraining enhancer-promoter interactions (Dixon et al. 2015).
Several methods have been developed to study chromatin interactions: Chromo-
some conformation capture (3C) (Dekker et al. 2002) and its derivatives 4C (circular
3C) (Simonis et al. 2006) and 5C (3C-carbon-copy) (Dostie et al. 2006) can detect
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long-range interactions of specific loci or within confined genomic regions (&1 Mb)
by ligation of cross-linked DNA fragment ends. Hi-C (Lieberman-Aiden et al. 2009)
provides genome-wide long-range interaction at higher resolution (up to 1 kb). Chro-
matin interaction analysis using paired-end tag sequencing (ChIA-PET) utilizes the
presence of cohesin at the bondaries of chromatin loops, as it identifies chromatin in-
teraction sites that are bound by a specific factor (e.g. cohesin) via ChIP (Fullwood
et al. 2009; Hnisz et al. 2016b).
These methods provided chromatin interaction maps for various species and cell
types that show that TADs are highly conserved between cell types and across
species and usually span about 1 MB (Dixon et al. 2012; Li et al. 2016; Schmitt et
al. 2016). Cohesin and CTCF also form loop structures inside TADs, called insulated
neighborhoods, that span &190 kb and organize cell identity genes in clusters with
their enhancers (Dowen et al. 2014; Hnisz et al. 2016a). The disruption of insulated
neighborhoods has been linked to cancer, as the correct formation of insulating sites
prevents activation of proto-oncogenes by enhancers (Hnisz et al. 2016b).
Chromatin interaction maps support the model in which enhancers and promot-
ers are brought close to each other by looping (Figure 2).
Cohesin
Target gene
Enhancer
Pol II
MediatorCTCF
TAD
nucleus insulated
neighborhood
Figure 2: Chromatin in the nucleus is organized in TADs, which are composed of insulated
neighborhoods. Chromatin loops, which are established by cohesin and Mediator, bring enhancers
and target promoters close to each other. Adapted from (Hnisz et al. 2016a; Shlyueva et al. 2014;
Gonzalez-Sandoval et al. 2016).
2.3 Enhancer transcription
The role of enhancer transcription and/or eRNAs remains unclear (Li et al. 2016). It
is likely that the process of enhancer transcription has a functional role, maybe in re-
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cruiting chromatin remodelers through their association with transcribing Pol II (Grib-
nau et al. 2000). Consistent with this model, enhancer transcription can precede
target gene transcription (Arner et al. 2015; De Santa et al. 2010; Kaikkonen et al.
2013; Schaukowitch et al. 2014). It is also possible that eRNAs themselves have a
function, because eRNA knockdown may impair target gene activation (Ilott et al.
2014; Li et al. 2013; Schaukowitch et al. 2014). eRNA knockdown may also have
negative effects on promoter-enhancer pairing (Li et al. 2013), although some studies
came to different conclusions (Hah et al. 2013; Schaukowitch et al. 2014).
Several studies have shown that the transcription of eRNAs can be activated or
vary in a circadian manner (Fang et al. 2014; Kaikkonen et al. 2013; Step et al.
2014). Additionally, some eRNAs have a function in transcription activation: Via
interaction with the Mediator complex and the androgen receptor complex at the en-
hancer, KLK3 eRNA facilitates chromosomal looping and enhances gene expression
of KLK3 and KLK2 (Hsieh et al. 2014). In a single-gene study, it has been found
out that the eRNA is transcribed, then it interacts with the NELF complex, which
is subsequently released from Pol II at the target promoter Arc, and transcription
of Arc mRNA takes place (Schaukowitch et al. 2014). These results would suggest
that eRNAs need to be transcribed before their target genes in order to increase
their gene expression levels. Dynamic changes in eRNA and mRNA transcription
have been assessed via CAGE (cap analysis of gene expression) in 33 time courses
of different biological stimuli and across different cell types and organisms. This
study shows that in general eRNA expression can peak as early as 15 minutes after
stimulation and is followed by an induction of mRNA expression levels (Arner et al.
2015).
3 T-cell activation
T-cell activation is a widely studied model system to investigate the cellular re-
sponse to exogenous stimulation. Upon T-cell stimulation, the T-cell receptor
(TCR) and the costimulatory receptor CD28 are activated, leading to a signal-
ing cascade (Smith-Garvin et al. 2009). Phosphorylation of multiple factors at
the plasma membrane leads to recruitment and activation of PLC-g that cleaves
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PI(4,5)P2 in DAG and IP3. First, DAG binds and activates PKC✓, which leads to
activation and nuclear translocation of the transcription factors NF-B and AP-1.
Second, IP3 diffuses away from the plasma membrane and activates calcium channel
receptors on the endoplasmic reticulum (ER), increasing intracellular calcium ion
concentration and leading to activation of calmodulin and calcineurin. Calcineurin
activates NFAT that translocates to the nucleus and drives gene activation. T-cell
stimulation via the T-cell receptor and CD28 can be mimicked by addition of PMA
and ionomycin because phorbol esters activate PKC and calcium ionophores raise
intracellular calcium levels (Weiss et al. 1987).
The T-cell response involves rapid changes in gene expression (Cheadle et al.
2005; Diehn et al. 2002; Feske et al. 2001; Marrack et al. 2000; Raghavan et al. 2002;
Rogge et al. 2000). Responding genes were classified into immediate-early, early,
and late response genes based on changes in RNA levels. Immediate-early response
genes are transiently activated within the first hour after stimulation (Bahrami et
al. 2016). There are &40 immediate-early genes described, most of which code for
transcription factors such as FOS, FOSB, FRA1, JUNB, JUN, NFAT, NF-B and
EGR1 (Greenberg et al. 1984; Sheng et al. 1990). Several hours after stimulation,
immediate-early factors activate early and late response genes, including cytokines,
such as IL-2, TGF -b or IFN -g (Crabtree 1989; Ellisen et al. 2001). Despite these
studies, the immediate T-cell response and the primary events after T-cell stimula-
tion remain incompletely understood.
4 Transcriptome profiling
4.1 Quantification of RNA abundance
The abundance of RNA in a cell can be measured on a large scale by microarrays or
RNA sequencing (RNA-seq). These methods allow the genome-wide, high-resolution
quantification of gene expression.
Microarrays contain thousands of oligonucleotide DNA probes on their surface
that are complementary to specific genes of interest or genomic target loci. Mi-
croarrays allow the simultaneous measurement of gene expression for thousands
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of transcripts, for which probes are present on the microarray. After converting
the RNA probes to complementary DNA (cDNA), hybridization of flourescently la-
beled samples generates a optical signal, which is scanned and quantified (Shalon
et al. 1996). One limitation of microarrays is the restriction to known transcript se-
quences. Next-generation sequencing techniques overcome this limitation by direct
high-throughput sequencing of cDNA (RNA-seq). cDNA fragments with adaptors
ligated to their ends can be sequenced from one (single-end sequencing) or both
ends (paired-end sequencing). This generates million of reads of 30-400 bp in length
(depending on the sequencing platform) at low cost in a very short time (Mortazavi
et al. 2008; Wang et al. 2009b). RNA-seq is compatible with every species, but
it requires that the reference genome is known, as the sequenced reads need to be
mapped to the reference genome to determine their origin. This allows to quantify
the gene expression by counting reads at each locus of interest in the genome. One
advantage of RNA-seq is its power to detect low-abundance and novel transcripts.
The single-base resolution of RNA-seq also provides the potential to detect novel
5’ and 3’ transcript boundaries and alternative splicing isoforms (Mortazavi et al.
2008; Wang et al. 2009b).
In recent years, many variations of RNA-seq have been established that focus on
specific transcript properties. Some sequencing-based methods detect the usage of
specific transcription start sites by sequencing 5’ transcript ends (GRO-cap (Core
et al. 2014)) or alternative poly(A)-sites. Several methods assess nascent RNA by
nuclear run-on of isolated nuclei (GRO-seq (Core et al. 2008), PRO-seq (Kwak et
al. 2013)), by immunoprecipitation of Pol II and sequencing of Pol II-associated
transcripts (NET-seq (Churchman et al. 2011)), or by metabolic labeling (Miller
et al. 2011; Paulsen et al. 2014) (Section 4.2).
4.2 Metabolic labeling to measure RNA synthesis
The levels of RNA in an eukaryotic cell are the result of regulated synthesis and
degradation of RNA. Standard transcriptomics (e.g. RNA-seq) measure the total
RNA abundance. Due to the long half-lives of mRNA, and thus high levels of mRNA
in the cell, RNA-seq is not sensitive enough to observe fluctuations in transcript
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synthesis or degradation. Additionally, the large amount of stable mRNA in the cell
conceils ncRNAs that usually have a faster turnover (Schwalb et al. 2016).
Methods which measure the nascent RNA in a cell are sensitive to changes in the
RNA synthesis and are not biased by stable transcripts. Several methods have been
used to study nascent transcription that include arrest of Pol II in vivo and run-on in
vitro (Core et al. 2008; Kwak et al. 2013; García-Martínez et al. 2004). Transcription
can be arrested by sarkosyl, but this treatment inhibits cellular processes (Miller et
al. 2011). Therefore, to measure RNA synthesis in a non-perturbing manner in
vivo, nascent RNA can be marked by metabolic labeling (Cleary et al. 2005; Dölken
et al. 2008; Friedel et al. 2009; Kenzelmann et al. 2007; Miller et al. 2009) and
subsequently purified labeled transcripts can be quantified.
The additional advantage of unperturbing metabolic labeling is the inference
of transcript degradation rates. Degradation rates can be directly measured after
blocking transcription or heat shock perturbation (Grigull et al. 2004; Holstege et al.
1998; Lam et al. 2001; Wang et al. 2002), but both methods are perturbing the cel-
lular system. Metabolic labeling followed by kinetic modeling leads to unperturbed
RNA synthesis and degradation rates (Miller et al. 2011).
4.2.1 Dynamic Transcriptome Analysis (DTA)
Nascent RNA can be labeled by providing a labeling substrate such as 4-thiouracil
(4tU) or 4-thiouridine (4sU). During transcription, 4sUTP is incorporated into the
newly transcribed RNA instead of UTP. The thiol-labeled RNA (‘labeled RNA’)
can be isolated from the total pool of RNA (‘total RNA’) by biotinylation and
streptavidin-coated magnetic beads (Miller et al. 2011).
The nucleoside analog 4sU can be taken up by eukaryotic cells or by yeast cells
expressing the nucleoside transporter human equilibriative nucleoside transporter
(hENT1). Alternatively, 4tU can be used to label the budding yeast Saccharomyces
cerevisiae (S. cerevisiae) or the fission yeast Schizosaccharomyces pombe (S. pombe)
without the expression of an additional transporter. After the cellular uptake of
4tU, it gets efficiently converted to thiolated UTP (Eser et al. 2016).
4sU/4tU-labeled and total RNA fractions can then be quantified by microarray
measurements (Eser et al. 2013; Miller et al. 2011; Sun et al. 2012) or deep sequencing
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(4sU-seq/4tU-seq) (Eser et al. 2016; Schulz et al. 2013).
Comparative DTA (cDTA) is an extension of DTA, where S. pombe RNA is used
as internal standard for normalization of different S. cerevisiae samples. Labeled
S. pombe and S. cerevisiae cells are mixed in a defined ratio before cells lysis, total
RNA purification, labeled RNA extraction, and hybridization on microarrays. cDTA
allows to compare absolute changes between different samples (Sun et al. 2012).
4sU-seq/4tU-seq is more sensitive than RNA-seq in monitoring dynamic changes
in RNA levels and allows to estimate synthesis and degradation rates by kinetic
modeling (Sections 6 and 8.4).
4.2.2 Transient transcriptome sequencing
TT-seq (Schwalb et al. 2016) is based on 4sU-seq and aims at a uniform read dis-
tribution along long human transcripts, which is not given by 4sU-seq. Human
protein-coding genes are on average 67 kb long. With a estimated elongation rate
of &4 kb/min (Ardehali et al. 2009; Darzacq et al. 2007; Singh et al. 2009) poly-
merase transcribes about 20 kb during the 5 minute labeling pulse. Therefore,
during the short labeling pulse of 5 minutes, only a small 3’ part of nascent RNA
is labeled, while the 5’ regions were already pre-existing before the addition of 4sU
(Figure 3). Purification of labeled RNA fragments would result in the overrepresen-
tation of 5’ ends (5’ bias) that were not synthesized during the labeling pulse. To
overcome this bias, TT-seq was established. The RNA is fragmented via mild soni-
cation, yielding fragments of about 1.5 kb, before labeled RNA is purified (Figure 3).
The subsequent isolation of labeled fragments yields a transcript length-independent
distribution of nascent RNAs (Schwalb et al. 2016).
Therefore, TT-seq provides a framework to estimate synthesis and degradation
rates, observe transient RNAs, and observe fast changes in transcription kinetics in
the human system.
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Figure 3: Schematic view of the 4sU-seq and TT-seq protocols. Taken from (Schwalb et al. 2016).
Reprinted with permission from AAAS.
5 Conventional methods for modeling and normal-
ization of RNA-seq data
For RNA-seq and its derivatives, the abundance of biological RNA fragments is not
directly reflected in the observed read counts. The distribution of reads within a
single sequenced sample allows to draw conculsions on relative ratios of gene ex-
pression levels between different genes, as the read counts are linearily related to
the abundance of a transcript (Mortazavi et al. 2008). The absolute difference be-
tween different samples, however, cannot be directly estimated from sequenced read
numbers. The number of sequenced reads/fragments (read counts) per transcript
depends on the sequencing depth, i.e. how many reads have been sequenced for the
sample, the length of the transcript, and its abundance in the cell. Hence, the quan-
titative assessment of differential gene expression across different samples requires
normalization between samples that allows for comparisons between samples (Dillies
et al. 2013).
So far, many different models have been proposed to infer levels of gene-expression
and compare them quantitatively between different samples. A common normal-
ization in quantitative transcriptomics is the calculation of reads per kilobase per
million mapped reads (RPKM) for each transcript (Mortazavi et al. 2008). This
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value accounts for different sequencing depths per sample and varying gene lengths,
but is biased by highly-expressed transcripts (Bullard et al. 2010).
There are multiple tools that use statistical testing to infer differentially ex-
pressed genes while accounting for different sequencing depths between samples. In
order to test if observed read counts between samples are significant different, these
methods have to take into account the underlying distribution. Some methods as-
sume a Poisson distribution, as it approximates a multinomial distribution which
would reflect read counts that are independently sampled (Marioni et al. 2008; Wang
et al. 2009a). The problem with the Poisson distribution is that its variance is equal
to the mean. Overdispersion is a common feature in count data, where the variance
is high for low count numbers. Therefore, the Poisson distribution is not suited to
model count data. The negative binomial distribution (NB), which is determined by
a mean µ and variance  2, has been proposed to model count data (Whitaker 1914).
The edgeR package uses the NB read distribution to model read counts k
ij
for a gene
i in a sample j: k
ij
⇠ NB(µ
ij
, 
j
) with the dispersion parameter  
j
, while assuming
that mean and variance are related:  2
ij
= µ
ij
+  
j
µ
2
ij
(Robinson et al. 2007; Robin-
son et al. 2009). edgeR estimates the trimmed mean of M values (TMM), a weighed
trimmed mean of log expression ratios in two different conditions. The TMM is
inferred from gene-wide expression ratios under the assumption that the majority
of genes is not differentially expressed (Robinson et al. 2010). The TMM is used
to scale the total read counts per sample, obtaining the effective library size, and
therefore normalizing for variations in sequencing depth. Another commonly used
approach is DESeq, which addresses the library size normalization by linear scaling
of a condition-dependent gene-specific value q
ij
with the normalization factor s
j
to
obtain the expected count value for gene i in sample j, µ
ij
: µ
ij
= q
ij
s
j
(Anders
et al. 2010). The variance is estimated as the sum of the shot noise (uncertainty in
measuring a concentration by counting reads) and the sample-to-sample variation:
 
2 = s
j
µ
ij
+  s2
j
µ
2
ij
(Anders et al. 2012). DESeq2 also includes shrinkage of fold
changes for genes with low read counts, where the variance is usually higher com-
pared to highly expressed genes. Variability between replicates is handled with a
dispersion parameter (Love et al. 2014a; Love et al. 2014b).
All of the explained statistical methods are based on the hypothesis that the
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majority of genes is not differentially expressed. However, this is not always true
in experiments, as for example the knock-down or knock-out of a specific factor
could lead to a global down-regulation of cellular transcription. This issue can
only be assessed by the usage of internal standards in the experiment that are
not influenced by environmental stimuli or genetic perturbations. In the cDTA
method, RNA from a different organism is added to the samples of interest (Sun
et al. 2012) (Section 4.2). It is also possible to use synthetic spike-ins to infer
global normalization factors (Jiang et al. 2011; Lovén et al. 2012; Schwalb et al.
2016) (Section 8.1).
In the case of metabolic labeling with subsequent kinetic modeling the relative
ratio of newly-synthesized labeled RNA and total cellular RNA has to be estimated
in order to infer correct synthesis and degradation rates on an absolute scale. This
normalization can be achieved by scaling each sample with the ratio of purified RNA
quantities before and after labeled RNA purification (Rabani et al. 2011). In the
DRiLL model two normalization factors are estimated that account for the relative
abundance of 4sU-labeled RNA within the total RNA population and for a possible
cross-contamination of unlabeled RNA in the labeled RNA fraction (Rabani et al.
2014). The INSPEcT framework jointly estimates normalization factors and calcu-
lates synthesis, degradation, and processing rates from 4sU-seq and total RNA-seq
samples (de Pretis et al. 2015). In the case of multiple labeling time points, the
increase of the labeling fraction over time and hence its convergence to steady-state
levels can be used to estimate the normalization factor and the cross-contamination
rate (Eser et al. 2016). All of these approaches estimate these normalization fac-
tors jointly across all genes. However, they are limited in the detection of global
expression differences between samples.
6 Estimation of RNA metabolism kinetics
Standard transcriptomics combined with metabolic labeling can be used to model
transcription kinetics. A set of differential equations describes the RNA synthesis,
processing, and degradation processes. As it is reasonable to assume cytoplasmic
RNA levels decay proportionally to their level, degradation is usually modeled by
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first-order kinetics. Assuming that the cytoplasmic RNA amount T is degraded
proportionally to its overall concentration with rate   during time t, the following
differential equation can be derived:
dT
dt
=   T (1)
The solution of this differential equation gives an estimate about the RNA con-
centration at time t dependent on the initial RNA concentration T (0) assuming
exponential decay:
T (t) = T (0) · e  ·t (2)
The time t1/2, after which half of the initial RNA amount T (0) has been degraded,
can be derived by setting T (t) = 12T (0). Then,
t1/2 =
log(2)
 
. (3)
During steady-state, mRNA synthesis and degradation are in equilibrium.
The DTA method has been designed to extract synthesis and degradation rates
from 4sU-labeled and total RNA microarray measurements (Schwalb et al. 2012).
The change of steady-state labeled and total RNA levels L and T during labeling
time t can be described by
dL
dt
= µ   L (4)
and
dT
dt
= µ   T (5)
with constant synthesis rate µ and degradation rate   during labeling time t.
DRiLL extends the model above by estimating also processing rates (Rabani et al.
2011; Rabani et al. 2014). This model implies that pre-mRNA P is synthesized and
processed to mature RNA M in the nucleus before it gets exported to the cytoplasm,
where degradation takes place. This can be modeled by relying on the assumption
that pre-mRNA in the nucleus is not degraded and that the export to the cytoplasm
happens immediately after maturation. Additionally, when the labeling time is short
(<10 min), it can be assumed that 4sU-labeled RNA is mostly nuclear (Rabani et al.
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2011). Then, the labeled RNA fraction corresponds to pre-mRNA levels:
L = P (6)
and
T = P +M. (7)
Pre-mRNA levels are reduced by RNA processing at rate  :
dP
dt
= µ   P. (8)
Mature RNA levels evolve from processed pre-mRNA levels and are degraded at
rate  :
dM
dt
=  P    M. (9)
The INSPEcT software additionally accounts for the fact that 4sU-labeled RNA
can also contain mature RNA, so Equation (6) does not hold anymore. This is done
by calculating exonic and intron RPKM values in 4sU-labeled and total RNA-seq
samples that correspond to pre-mRNA and mRNA levels among 4sU-labeled and
total RNA, respectively (de Pretis et al. 2015).
Eser et al. fit the same model as described in Equations (8) and (9) to a time
series of multiple labeling time points, while accounting for increasing labeled RNA
fractions with longer labeling time, sequencing depth, 4tU labeling efficiency, and
cross-contamination of unlabeled RNAs in the labeled RNA fraction (Eser et al.
2016) (Section 19).
The development of TT-seq and its ability to measure nascent RNA unbiased
by the length of the gene (Section 4.2.2) offers the possiblity to determine local
synthesis and degradation rates at nucleotide resolution (Wachutka et al. 2016). The
reads mapping to exonic or intronic bases, or to exon-intron, intron-exon, and exon-
exon junctions are quantified in TT-seq and RNA-seq fractions and synthesis and
degradation rates can be estimated. The synthesis rate of individual phosphodiester
bonds corresponds to the transcription rate of exons, introns, or single junctions.
19
The degradation rate of phosphodiester bonds within exons or introns or bonds
spanning exon-exon junctions correspond to the degradation rate of the exon, intron
or junction, respectively. The degradation rate of bonds at exon-intron or intron-
exon junctions gives the splicing rate at these junctions (Figure 4) (Wachutka et al.
2016).
Figure 4: Synthesis and degradation rates at the level of individual phosphodiester bonds.
The degradation rate at donor and acceptor splice sites corresponds to the splicing rate. Taken
from (Wachutka et al. 2016).
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7 Aims and scope of this thesis
Transcription and its regulation by enhancers have been intensively studied (Sections
1 and 2). Especially the human T-cell response is a widely used model system (Sec-
tion 3). The development of high-resolution methods for transcriptome profiling
such as RNA-seq (Section 4) provides the opportunity to measure gene expression
on a genome-wide level and compare it across multiple experiments. However, differ-
ent samples need to be normalized properly in order to compare them (Section 5).
Most normalization methods are lacking a factor that accounts for global differ-
ences. Metabolic labeling of RNA measures RNA synthesis rate, but in order to
infer RNA degradation rates correctly labeled and total RNA fractions need to be
scaled relative to each other (Section 6).
In the first part of this thesis, I introduce a model to normalize TT-seq (or
4sU/4tU-seq) and RNA-seq data relative to each other, based on the use of artifical,
in vitro labeled spike-ins. This normalization corrects for sequencing depth and the
ratio of labeled to total RNA as well as for the cross-contamination of unlabeled
RNA in the labeled fraction. The resulting normalization values are then used
to model synthesis and degradation rates jointly across replicates of TT-seq and
RNA-seq data.
In the second part of the thesis, I investigate the relationship between tran-
scription from enhancers and promoters during the human T-cell response. To
monitor immediate transcriptional changes after T-cell stimulation we use transient
transcriptome sequencing (TT-seq) (Section 4.2.2). TT-seq was developed recently
to detect short-lived RNAs such as eRNAs in human cells, and to estimate RNA
synthesis and degradation rates (Schwalb et al. 2016) (Section 18). TT-seq involves
short, 5 minute labeling of nascent RNA with 4-thiouridine (4sU). RNA is then frag-
mented, and the labeled RNA fragments are sequenced, providing a genome-wide
view of RNA synthesis during the 5 minute labeling pulse. TT-seq is a sensitive
method to detect eRNAs, because it has higher sensitivity than RNA-seq in detect-
ing short-lived RNAs. It is more sensitive than standard 4sU labeling in detecting
short RNAs because its fragmentation step confers a transcript length-independent
sampling of the nascent transcriptome (Schwalb et al. 2016). Hence, TT-seq should
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be ideally suited to map changes in eRNA and mRNA production during transcrip-
tional activation, but this was not yet demonstrated. Studies, which investigate
the timing of eRNA and mRNA activation, lack very early response systems, are
not conducted genome-wide or are not performed in vivo. The T-cell activation
system provides an optimal setup to study the very rapid gene expression response
within minutes, that has not yet been studied applying the sensitivity of TT-seq
to very early time points after activation. The temporal resolution of eRNA and
mRNA expression changes are of special interest, as it is still unclear, if the eRNA
transcript itself has a function on mRNA transcription regulation. eRNAs that are
transcribed before their promoters could have a function on the gene expression,
while co-transcribed eRNAs are more likely a transcriptional by-product without a
function. Therefore, I investigate the timing of eRNA and mRNA production during
early T-cell activation with TT-seq.
In the third part of this thesis, I present additional results that were obtained in
collaborations applying 4tU-seq/TT-seq and the normalization method to different
cell types and organisms.
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Part II
Materials and Methods
In the following, I introduce mathematical and computational methods that were
developed and/or applied to achieve the results presented in Section III. The first
section presents the mathematical basis for the normalization based on spike-in read
counts and estimation of synthesis and degradation rates from TT-seq and RNA-seq
data (Section 8). The second part describes the analysis procedure of TT-seq data
derived during T-cell activation (Section 9).
8 Normalization and modeling of TT-seq count data
This section presents the mathematical model to normalize TT-seq and RNA-seq
data relative to each other using spike-ins. The correct ratio of labeled and total
RNA in a cell can be used to infer synthesis and degradation rates. This model was
implemented as an R package, for which a manuscript is under preparation. It has
been first applied to human K562 data (Schwalb et al. 2016) (Section 18).
8.1 Spike-ins
Sequencing RNA involves the conversion of RNA to cDNA, fragmentation, and
polymerase chain reaction (PCR) amplification of doule-stranded cDNA. Library
preparation kits require specific volumes and concentrations of cDNA material as
input. Therefore, varying RNA volumes due to biological variations between samples
are concealed. The comparison of different RNA-seq samples regarding global effects
on RNA expression has been a tedious task (Section 5). In order to account for global
variations between samples from different experimental conditions, RNA from a
related organism is often used as internal standard, such as S. pombe RNA for
S. cerevisiae RNA measurements (Miller et al. 2012; Sun et al. 2012; Sun et al.
2013). In the case of metabolically labeled RNA samples, such as 4tU/4sU-seq or
TT-seq, the labeling efficiency with 4sU is another factor that could be addressed
during normalization. Additionally, the ratio of labeled RNA to total RNA in the
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cells cannot directly be read out from the sequencing results, as same input volumes
are used for the library preparation. Therefore, an internal control that accounts for
labeling with 4sU is needed, which can be achieved by synthetic spike-ins from the
External RNA Controls Consortium (ERCC) (External RNA Controls Consortium
2005). These spike-ins mimic eukaryotic RNA sequences and can be transcribed and
labeled in vitro with 4sU (Frühauf 2015).
Katja Frühauf selected the ERCC spike-ins displayed in Table 1 based on the fol-
lowing criteria: similar length, similar uridine (U) content, and varying GC content
between 30% and 50% (Frühauf 2015). Spike-ins were amplified via PCR with the
forward primer including the T7 promoter sequence to facilitate in vitro transcrip-
tion from the PCR product. Spike-ins were transcribed in vitro with either only
UTP (‘unlabeled spike-ins’: Spike 5, Spike 9, Spike 12) or with 1:10 4sUTP:UTP
ratio (‘labeled spike-ins’: Spike 2, Spike 4, Spike 8) (Schwalb et al. 2016). The
spike-in sequences can be found in Appendix Section 24.1.
Spike-in ERCC-ID length number of Us GC content [%] 4sU labeled
Spike 2 ERCC-00043 1023 303 33 yes
Spike 12 ERCC-00170 1023 316 34 no
Spike 4 ERCC-00136 1033 268 42 yes
Spike 5 ERCC-00145 1042 266 44 no
Spike 8 ERCC-00092 1124 296 50 yes
Spike 9 ERCC-00002 1061 266 51 no
Table 1: Spike-ins used for normalization of TT-seq and RNA-seq data.
Margaux Michel prepared a stock of in vitro labeled and unlabeled spike-ins,
which were mixed in equal amounts. This spike-in mix was used for the TT-seq
experiments discussed in this thesis (Michel 2016). Detailed experimental methods
can be found in Section 24.2. The same volume of spike-ins relative to the cell
number was added to the cell lysate of every sample.
The artifical spike-ins are subjected to RNA isolation, fragmentation and labeled
RNA purification, together with the sample of interest. In the total RNA fraction,
all spike-ins should be present to a similar extend, and therefore have similar read
counts after sequencing. The labeled RNA fraction should be depleted of unlabeled
spike-ins due to labeled RNA purification.
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8.2 Modeling count data obtained via sequencing 4sU-labeled
and total RNA fractions
We propose a statistical model that complements the usage of artificial spike-ins
in TT-seq and RNA-seq experiments. It describes observed read counts k
ij
for a
gene i in a sample j by gene-specific labeled and unlabeled RNA amounts, while
accounting for various scaling factors.
In the following, the term feature describes either a gene or a spike-in, i.e. a
region of the genome to which reads could be mapped to and counted. Let L
i
be
the effective length of feature i. The effective length L
i
is the absolute length L⇤
i
of
feature i minus the read length L
R
.
L
i
= L⇤
i
  L
R
(10)
The effective length represents the number of possible start positions of a read
so that it maps with its entire length to the feature.
For every feature i, the number of expected reads in a sample j without labeled
RNA purification (‘total RNA’, T ) is dependent on the effective length L
i
, the
sequencing depth  
j
, the labeled and unlabeled RNA concentrations ↵
ij
and  
ij
, the
RNA extraction efficiency  
j
and the number of cells N used for the experiment.
Hence, the expected number of counts E(kT
ij
) can be modeled as:
E(kT
ij
) = L
i
·  
j
· (↵
ij
+  
ij
) ·  
j
·N. (11)
In a sample j with labeled RNA purification, the amount of labeled RNA ↵
ij
is dependent on the purification efficiency  
j
for the labeled fraction. In theory, no
unlabeled RNA fragments should appear in the labeled fraction, but due to some
unspecific binding during labeled RNA purification we need to adjust for unlabeled
RNA fragments by the cross-contamination rate ✏
j
. The cross-contamination rate is
relative to the total RNA amount in the sample. The number of expected reads for
feature i in a sample j with labeled RNA (L) purification can then be explained by
E
 
k
L
ij
 
= L
i
·  
j
· ( 
j
↵
ij
+ ✏
j
 
ij
) ·  
j
·N. (12)
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Note, Equation (11) can be derived from Equation (12) by setting  
j
= 1 and ✏
j
= 1.
Hence, in a total RNA sample we get 100% of the labeled RNA (labeled RNA
purification efficiency   = 1) and 100% of the unlabeled RNA (cross-contamination
rate ✏ = 1).
For labeled spike-ins i, the amount of unlabeled RNA  
ij
= 0, since we assume
every molecule is sufficiently labeled. The expected number of counts E(kT
ij
) for a
labeled spike-in i in a total RNA sample j can be formulated as:
E(kT
ij
) = L
i
·  
j
· ↵
i
. (13)
For a sample j with labeled RNA purification we get
E(kL
ij
) = L
i
·  
j
·  
j
· ↵
i
. (14)
Analogous to labeled spike-ins, for an unlabeled spike-in i, the amount of labeled
RNA ↵
ij
= 0, since they were reverse transcribed in the absence of 4sUTP. Hence,
the expected number of counts in total and labeled RNA samples for an unlabeled
spike-in i can be formulated as:
E(kT
ij
) = L
i
·  
j
·  
i
(15)
and
E(kL
ij
) = L
i
·  
j
· ✏
j
·  
i
. (16)
From gene annotations and spike-in sequences, we can derive the effective length
L
i
for each feature i. For simplification, we set N = 1, because the number of cells
is theoretically identical across all our samples (50 Mio, see Section 24.2).
The estimation of absolute values for the unknown parameters  , ✏, and   is not
possible, as they would always be relative to each other. Therefore, we set  
j
= 1.
Setting ↵
i
= 1 in Equation (14), we can get the sequencing depth  
j
for every sample
j. From Equation (16) with  
i
= 1 we can derive the cross-contamination rate ✏
j
for every sample j.
For each gene i, ↵
ij
,  
ij
, and  
j
are not identifiable from Equations (11 and 12).
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This means we cannot control for RNA extraction efficiency and set  
j
= 1. Thus,
Equations (11)-(16) can be reformulated as:
E(k
ij
) = L
i
·  
j
· (↵
i
+ ✏
j
 
i
) (17)
with ✏
j
= 1 for total RNA samples.
8.3 A model for normalization with spike-ins
The labeled and unlabeled spike-ins can be used to normalize TT-seq (‘labeled
RNA’) and RNA-seq (‘total RNA’) samples and set them into relation to each other.
Unlabeled spike-ins mimic unlabeled RNA fragments, while labeled spike-ins imitate
newly synthesized, labeled RNA fragments. The spike-ins undergo the same steps
of sample preparation as real RNA. All reads obtained by sequencing are mapped to
a combined reference genome with additional ‘chromosomes’ containing the spike-in
sequences (Appendix Section 24.1). The mapped reads on the spike-in sequences
are then counted for each spike-in individually. Our proposed statistical model to
normalize TT-seq and RNA-seq samples is based on these spike-in read counts.
In order to estimate the sample-specific parameters for sequencing depth  
j
and
cross-contamination ✏
j
we perform a multiple regression analysis on spike-in read
counts.
Equation (17) can be extended to also allow for some variability between spike-
ins, e.g. sequence variations that lead to different polymerase chain reaction (PCR)
amplification biases, by multiplication with a spike-in specific parameter ⇢
i
:
E(k
ij
) = L
i
·  
j
· (↵
i
+ ✏
j
 
i
) · ⇢
i
. (18)
We set ↵
i
= 1 and  
i
= 0 for the labeled spike-ins, and ↵
i
= 0 and  
i
= 1 for the
unlabeled spike-ins. This assumption holds true because we assume that in vitro
transcription in the presence of 4sU works efficiently and the spike-ins are labeled
sufficiently for purification. We use the same volumes for all spike-ins in all samples
(see Section 8.1), therefore, their relative ratio is 1. We fit a Generalized Linear
Model (GLM) to estimate  
j
, ✏
j
, and ⇢
i
. As the effective length L
i
for each spike-in
27
i is known, we use it as offset in the linear predictor:
log(E(k
ij
)) = log(L
i
) + log( 
j
) + log(✏
j
) + log(⇢
i
). (19)
Using a GLM allows the response variables (i.e. the observed read counts) to
follow other error distributions than a normal distribution. A negative binomial
distribution is assumed to model the expected read counts. In count data, small
numbers often have a large variation. This is the so-called overdispersion (Cameron
et al. 1998), which is also true for sequencing read counts. Therefore, an appropri-
ate distribution needs to be chosen to model read counts. While for the Poisson
distribution variance and mean are equal, the negative binomial distribution is a
generalization that allows for a larger variance, and it is commonly used to model
sequencing read counts (Anders et al. 2010; Eser et al. 2016).
For the spike-in read counts, the GLM is fitted jointly for all samples by max-
imum likelihood (ML) estimation. Thereby, all spike-ins in one sample contribute
to its sequencing depth value  , the unlabeled spike-ins in a labeled sample to its
cross-contamination estimate ✏, and the read counts for each spike-in across the
different samples contribute to the spike-in specific factor ⇢ (Table 2).
4sU Sample sequencingdepth
cross-
contamination
rate
spike-in
specific
factor
Spike 2 yes
TT-seq
 1 ⇢Spike2
Spike 4 yes
 1 ⇢Spike4
Spike 5 no
 1 ✏1 ⇢Spike5
Spike 8 yes
 1 ⇢Spike8
Spike 9 no
 1 ✏1 ⇢Spike9
Spike 12 no
 1 ✏1 ⇢Spike12
Spike 2 yes
RNA-seq
 2 1 ⇢Spike2
Spike 4 yes
 2 1 ⇢Spike4
Spike 5 no
 2 1 ⇢Spike5
Spike 8 yes
 2 1 ⇢Spike8
Spike 9 no
 2 1 ⇢Spike9
Spike 12 no
 2 1 ⇢Spike12
Table 2: Contribution of spike-ins to global scaling factors in different samples.
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8.4 A model for estimating synthesis rates and half-lives dur-
ing steady state
The method to estimate synthesis and degradation rates from 4sU-labeled and to-
tal RNA-seq data is based on previous studies (Miller et al. 2011; Schwalb 2012).
Steady-state conditions are assumed, meaning the amount of RNA in the cell is con-
stant and there is a dynamic equilibrium of a constant RNA synthesis and decay.
After applying the model from Section 8.3 to spike-in read counts, the values
for sequencing depth  
j
and cross-contamination ✏
j
per sample j are fixed and used
for the estimation of gene-specific parameters. Using Equations (11) and (12), the
RNA amounts ↵
ij
and  
ij
can be estimated independently for every gene.
To account for the overdispersion of count data, a negative binomial function is
assumed to model the read counts:
E(k
ij
) ⇠ NB(µ
ij
, 
j
). (20)
The dispersion parameter  
j
is estimated per gene individually for labeled samples
(4sU/4tU-seq, TT-seq) and total RNA samples, using the DESeq2 implementa-
tion (Love et al. 2014b).
This model is fitted by maximum likelihood to transcript read counts to provide
estimates of the labeled and unlabeled RNA amounts ↵
i
and  
i
for a pair of TT-seq
and RNA-seq measurements. The total RNA amount  
i
for a gene i is the sum of
labeled and unlabeled RNA amounts per cell:
 
i
= ↵
i
+  
i
. (21)
Previous studies (Miller et al. 2011) have shown that labeled and total RNA amounts
↵
i
and  
i
can be explained by the following equations:
↵
i
=
µ
i
 
i
·
 
1  e  i·t
 
(22)
and
 
i
=
µ
i
 
i
. (23)
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Therefore,
↵
i
+  
i
=
µ
i
 
i
. (24)
The synthesis rate µ
i
and the degradation rate  
i
can be calculated from Equa-
tions (22) and (24) assuming first-order kinetics:
 
i
=  1
t
· log
✓
 
i
↵
i
+  
i
◆
, (25)
and
µ
i
= (a
i
+  
i
) ·  
i
. (26)
Assuming exponential decay, gene-specific half-lives t1/2,i can be calculated from the
estimated degradation rates (see Section 6):
t1/2,i =
log(2)
 
i
. (27)
The estimated half-life times are on an absolute level (in minutes), but synthesis
rates are on an arbitrary scale. Absolute synthesis rates can be obtained by scaling
the values, so that total RNA levels match reported expression levels (Eser et al.
2016).
By applying this model individually to exon read counts and intron read counts,
we can obtain local synthesis and degradation rates, which reflect synthesis rates
and half-lives per nucleotide bond. Note that for data sets where the steady state
assumption does not hold (e.g. activation time course), this model is not sufficient.
8.5 Implementation and availability
The model for normalization with spike-ins and subsequent estimation of synthesis
and degradation rates was implemented in R (R Development Core Team 2011).
Fitting this model to the observed spike-in read counts is done using the R func-
tion glm.nb from the MASS package (Venables et al. 2002) with the default ‘log’ link
function. An open source R/Bioconductor package is under preparation in collabora-
tion with Leonhard Wachutka and Julien Gagneur. The package includes additional
functionalities such as counting reads for specific features and estimating splicing
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rates thereby using the functionalities of the SummarizedExperiment-class (Morgan
et al. 2016).
9 Analysis of a TT-seq data set obtained from an
activation time course in human T-cells
This section describes computational procedures and methods that were carried out
to analyze a set of TT-seq and RNA-seq data sets from an activation time course of
human T-cells. Detailed experimental methods can be found in Section 24.2. The
results are presented in Section III.
The methods described here have been published in:
TT-seq captures enhancer landscapes immediately after T-cell stimulation
M. Michel*, C. Demel*, B. Zacher, B. Schwalb, S. Krebs, H. Blum, J. Gagneur, and P. Cramer
Molecular Systems Biology (2017)
For detailed author contributions see page ix.
9.1 Replicate measurements
We prepared TT-seq and total RNA-seq libraries for two biological replicates. For
total RNA-seq, there were essentially no significant changes between time points,
and the samples showed very high correlations (Spearman correlation   0.98) and
can be seen as replicates (Figure A1). Replicate TT-seq libraries for time points
0 min and 10 min after T-cell activation were obtained and showed high correlation
(Spearman correlation coefficient 0.97, Appendix Figure A2). Based on these re-
sults, it was clear that the data are highly reproducible and of high quality, making
further replicate measurements obsolete. For all subsequent analyses, replicates were
averaged after size factor normalization, where available. For transcriptome anno-
tation (Section 9.5), all TT-seq samples were used, irrespective of their sequencing
depth, as GenoSTAN (Zacher et al. 2017) places more weight on deeper sequenced
samples.
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9.2 Sequencing data processing
Paired-end 50 base reads with additional 6 base reads of unique barcodes were
obtained for each of the samples. Reads were demultiplexed and 150-250 Mio read
pairs per sample were mapped unambiguously with STAR (version 2.3.0) (Dobin et
al. 2015) to the hg20/hg38 (GRCh38) genome assembly (Human Genome Reference
Consortium). Samtools (Li et al. 2009) was used to quality-filter SAM files, whereby
alignments with MAPQ smaller than 7 (-q 7 ) were skipped and only proper pairs
(-f99, -f147, -f83, -f163 ) were selected. Further data processing was carried out
using the R/Bioconductor environment (Gentleman et al. 2004; R Development
Core Team 2011).
9.3 Data availability
The sequencing data sets have been deposited in the Gene Expression Omnibus
(GEO) database under accession code GSE85201.
9.4 Antisense correction
For merged transcribed regions from GENCODE, we selected strand-specific ge-
nomic regions where no antisense annotation existed in GENCODE. This ensured
to only take unique regions into account where antisense transcription should not
be present. For all genomic positions in those regions, where the sense coverage
exceeded 100 reads (i.e. highly expressed regions), we calculated the median ratio
of antisense-to-sense coverage (including one pseudo-count). This value provides
an estimate of the antisense bias (c) in every sample. We corrected the observed
coverage/read counts for Watson and Crick strands, respectively, by solving the fol-
lowing formulas, which assume that the observed sense coverage is the sum of ‘real’
sense coverage and a small percentage (i.e. the antisense bias value c) of the ‘real’
antisense coverage:
Coverage
sense
real
=
Coverage
sense
observed
+ c · Coverageantisense
observed
1  c2 . (28)
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For antisense correction of coverage profiles, the antisense coverage was averaged in
a symmetrical 51 nt window around the position on the sense strand which should
be normalized. For all further analyses (including transcriptome annotation, calcu-
lation of expression values, fold changes, and synthesis/degradation rates) antisense-
corrected feature counts (rounded to the nearest integer) were used.
9.5 Transcription Unit (TU) annotation and classification
Genome-wide strand-specific coverage was calculated from fragment midpoints in
consecutive 200 bp bins throughout the genome for all TT-seq samples. Binning re-
duced the number of uncovered positions within expressed transcripts and increased
the sensitivity for detection of lowly synthesized transcripts. To overcome antisense
bias due to highly expressed genes, an antisense correction was performed on each
bin (as described in the previous paragraph). A pseudo-count was added to each
bin to mask noisy signals. The R/Bioconductor package GenoSTAN (Zacher et
al. 2017) was used to learn a two-state hidden Markov model with a PoissonLog-
Normal emission distribution in order to segment the genome into ‘transcribed’ and
‘untranscribed’ states, which resulted in 139,507 transcribed regions.
Transcription units (TUs) that overlapped at least to 20% of their length with
a protein-coding gene or a lincRNA annotated in GENCODE (gtf column ‘tran-
script_type’ either ‘protein_coding’ or ‘lincRNA’) and overlapped with an exon of
the corresponding annotated feature, were classified as protein-coding/lincRNA, the
rest was assumed to be ncRNAs. TUs mapping to exons of the same protein-coding
gene/lincRNA were combined. In order to filter spurious predictions a minimal ex-
pression threshold for TUs was defined based on overlap with genes annotated in
GENCODE. The threshold was optimized using the Jaccard index criterion, and
resulted in 27,558 TUs with minimal 16.5 reads per kilobase (RPK) (Figure 6B).
In order to overcome low expression or mappability issues, ncRNAs that are only
200 bp (1 bin) apart, were merged. Subsequently, TU start and end sites were refined
to nucleotide precision by finding borders of abrupt coverage increase or decrease
between two consecutive segments in the two 200 bp bins located around the initially
assigned start and stop sites via fitting a piecewise constant curve to the coverage
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profiles (whole fragments) for all TT-seq samples using the segmentation method
from the R/Bioconductor package tilingArray (Huber et al. 2006). Overlapping
transcripts (arising through overlaps with multiple annotated genes) were merged
using the reduce function from the GenomicRanges package and assigned the cor-
responding protein-coding or lincRNAs GENCODE ID, if existing. 612 annotated
transcripts (that were included to calculate DESeq size factors) that overlapped
with multiple protein-coding genes by at least 75% of the GENCODE transcript
length and 20% of our transcript were removed from further analyses, because they
could not be clearly assigned to one gene. Protein-coding transcripts shorter than
5 kb and overlapping less than 10% with any GENCODE protein-coding gene were
classified as ‘ncRNA’. All ncRNAs with starting sites up to 1 kb downstream of a
protein-coding gene on the sense strand were omitted in enhancer analysis or eRNA
comparisons, as these reads might come from read-through transcription after the
transcript sequence. This resulted in 22,141 non-ambiguously classified RNAs (8,878
protein-coding genes, 590 lincRNAs, and 12,673 ncRNAs), on which the rest of the
analysis was focused. The class of eRNAs was comprised of 5,616 of our ncRNAs,
where either the transcript or the region 1 kb upstream of the ncRNA overlapped
with an enhancer annotated by GenoSTAN in at least one T-cell line (Zacher et al.
2017).
9.6 Estimation of RNA synthesis rates and half-lives
To overcome inconsistent coverage throughout a gene due to splicing and multi-
ple isoforms, constitutive exons (Bullard et al. 2010) were determined for all our
mRNA and lincRNA transcripts. Read counts for those constitutive exons and all
other ncRNA classes across all TT-seq and RNA-seq samples were calculated using
HTSeq (Anders et al. 2014). To estimate rates of RNA transcription and degradation
we used the same approach as described in (Schwalb et al. 2016) and in Section 8.
Briefly, we used a statistical model that describes read counts k
ij
(in a TT-seq or
RNA-seq sample) by the length of the feature (spike-in/transcript) i, L
i
, and feature-
specific labeled und unlabeled RNA amounts, ↵
i
and  
i
: E(k
ij
) = L
i
 
j
(↵
ij
+ ✏
j
 
ij
).
We calculated the sequencing depths  
j
and cross-contamination "
j
rates per sample
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j based on the spike-in read counts by setting ↵
ij
= 1 and  
ij
= 0 for labeled spike-
ins, and ↵
ij
= 0 and  
ij
= 1 for unlabeled spike-ins. In a total RNA-seq sample,
"
j
is fixed to 1, and in a TT-seq sample "
j
is close to 0, as we enrich for labeled
RNA. Then, this model was fitted by maximum likelihood to transcript read counts
to provide estimates of the labeled and unlabeled RNA amounts ↵
i
and  
i
for a pair
of TT-seq and RNA-seq measurements. The synthesis rate µ
i
and the degradation
rate  
i
were calculated from ↵
i
and  
i
assuming first-order kinetics as in (Miller
et al. 2011) in the following way:  
i
=  1
t
log( 
i
/(↵
i
+  
i
)) and µ
i
= (a
i
+  
i
) 
i
.
9.7 Differential gene expression
Gene expression fold changes upon T-cell stimulation for each time point were cal-
culated using the R/Bioconductor implementation of DESeq2 (Love et al. 2014b).
The DESeq size factor was only estimated on our set of protein-coding genes. Dif-
ferentially expressed genes were identified applying a fold change cutoff of 2 and an
adjusted P -value cutoff of 0.05 comparing each time point to the 0 min measure-
ments. For the absolute numbers of genes with changed synthesis, we checked if the
TT-seq read count is significantly (adjusted P -value  0.05) changed at least 2-fold
at any time point compared to time point 0 min.
9.8 Motif analysis
DNA motifs in the form of position weight matrices (PWMs) were downloaded from
the JASPAR database via the R/Bioconductor package JASPAR2016 (Tan 2015).
Each PWM was screened against a positive and a negative set of sequences (e.g.
250 bp upstream sequences of eRNAs and remaining ncRNAs) with the searchSeq
function in the TFBSTools package (Tan et al. 2016). We defined a cutoff to dis-
tinguish between motif occurrence and not-occurrence as 80% of the maximal score
that the PWM could reach. The number of sequences in which the motif occurred
was counted for the positive and negative set, and an odds ratio was calculated.
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9.9 eRNA-mRNA pairing
We paired all eRNAs and mRNAs in all possible combinations, as long as both
transcript TSSs are within the same insulated neighborhood, defined by ChIA-PET
Anchor sites (Section 9.10) using the findOverlaps function from the GenomicRanges
package (Lawrence et al. 2013). Pairs were removed, where the eRNA TSS fell into
the region [TSS; TSS+1000] around the protein-coding gene’s TSS.
9.10 External data processing
Experimentally validated enhancers were downloaded from the VISTA enhancer
browser (http://enhancer.lbl.gov/frnt_page_n.shtml). ENCODE DNase-seq
raw coverage files (for Figure 10D) and peak files (for Figure 9) for Jurkat cells were
retrieved from
https://genome.ucsc.edu/ENCODE/dataMatrix/encodeDataMatrixHuman.html
and replicates were merged. Enhancer and DNaseI hypersensitivity sites (DHS)
coordinates were converted to hg20 coordinates using the liftover function in the
R/Bioconductor package rtracklayer (Lawrence et al. 2009). ChIA-PET interac-
tion domains processed with the Mango pipeline were downloaded from a previous
study (Hnisz et al. 2016b) and were selected for P -values < 0.2. ChIA-PET An-
chor sites were converted to hg20 coordinates using the liftover function in the
R/Bioconductor package rtracklayer (Lawrence et al. 2009) followed by a reduce
with min.gapwidth=60 which closes 90% of the gaps arising by liftover, in order to
get continuous genomic regions.
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Part III
Results and Discussion
All results presented in this section were obtained in collaboration with Margaux
Michel and are published in:
TT-seq captures enhancer landscapes immediately after T-cell stimulation
M. Michel*, C. Demel*, B. Zacher, B. Schwalb, S. Krebs, H. Blum, J. Gagneur, and P. Cramer
Molecular Systems Biology (2017)
The full article with supplementary materials and tables can be found at http:
// msb. embopress. org/ content/ 13/ 3/ 920 .
Contribution: I carried out all bioinformatics analyses for this project.
In this study, we use TT-seq to monitor the immediate T-cell response over the
first 15 min after cell stimulation. We identify new immediate, direct target genes
of the T-cell response, and show that activation of immediate enhancers and pro-
moters, as defined by RNA production, occurs simultaneously. The results also
establish TT-seq as a simple-to-use, very sensitive tool to investigate transcriptional
responses at high temporal resolution, ideally suited to monitor rapid changes in
enhancer landscapes and in transcriptional programs during cellular differentiation
and reprogramming.
10 Monitoring the immediate T-cell response
We monitored immediate changes in RNA synthesis in Jurkat T-cells during the first
15 min after stimulation with ionomycin and PMA using both TT-seq and RNA-seq
(Figure 5A, Sections 9.2 and 24.2, Appendix Figures A1 and A2). We selected
time points before stimulation (0 min), and 5, 10, and 15 min after stimulation.
The TT-seq data revealed strong up- and down-regulation of mRNA synthesis for
immediately responding genes (Figures 5B and C). In TT-seq data, we also observed
a high coverage of intronic regions and regions downstream of the polyadenylation
site (PAS, annotated by GENCODE (Harrow et al. 2012)), demonstrating that
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Figure 5: TT-seq analysis of immediate response to T-cell stimulation. (A) Experimental design.
RNA in cells was labeled with 4-thiouracile (4sU) for consecutive 5 minute intervals. Total and 4sU-
labeled RNA was extracted before T-cell stimulation and 5, 10, and 15 min after T-cell stimulation
and subjected to deep-sequencing. (B) Exemplary genome browser view for an upregulated mRNA
(JUN). Upper panel: TT-seq data for 0, 5, 10 and 15 min after stimulation; lower panel: total
RNA-seq data for 0, 5, 10 and 15 min after stimulation. (C) Exemplary genome browser view for
a downregulated mRNA (NKX3-1), analogous to (B).
TT-seq could trap short-lived RNA (Figures 5B and C).
We combined the TT-seq data to segment the genome into transcribed and non-
transcribed regions using GenoSTAN (Zacher et al. 2017). Then, we automati-
cally annotated a total of 22,141 transcribed regions (‘transcripts’) before and after
T-cell stimulation (RPK cutoff = 16.5, Section 9.5, Figure 6). Comparison with the
GENCODE annotation (Harrow et al. 2012) enabled us to classify our annotated
transcripts into 8,878 mRNAs, 590 long non-coding RNAs (lincRNAs), by requiring
at least 20% of the transcribed region to overlap with GENCODE annotated ‘pro-
tein_coding’ or ‘lincRNA’ (long, intervening noncoding RNA that can be found in
evolutionarily conserved, intergenic regions) transcripts (Section 9.5). The 12,673
remaining transcripts we categorized as non-coding RNAs (ncRNAs) (Figure 6C).
These RNAs may contain additional long non-coding RNAs that don’t fall into
GENCODE’s ‘lincRNA’ definition (Section 9.5).
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Figure 6: Annotation of transcripts. (A) Segmentation workflow. The Watson and Crick strands
are in dark blue and green, respectively. The top 8 tracks show antisense-corrected TT-seq data
tracks (log2 scale) that were used as input for GenoSTAN. The other tracks indicate the step-
wise annotation of transcripts. From the GENCODE annotation, only full transcripts with tran-
script_support_level 1 are depicted. (B) Jaccard index (compared to GENCODE annotation) for
different choices of thresholds (x-axis: Reads Per Kilobase (RPK)). The red line indicates the se-
lected RPK value where the Jaccard index reaches the maximal value. (C) Number of transcripts
per transcript class. (D) Distribution of transcript lengths per transcript class. Box limits are the
first and third quartiles, the band inside the box is the median. The ends of the whiskers extend
the box by 1.5 times the interquartile range.
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The length distribution of RNAs in these classes (Figure 6D) resembled that in
our previous study of human K562 cells (Schwalb et al. 2016). Steady-state RNA
synthesis rate and half-life distributions also agreed with previous results (Figure 7,
Section 9.6). Taken together, we obtained a transcriptome annotation for T-cells
that included both stable transcripts present during steady-state growth and short-
lived RNAs that are produced immediately after stimulation.
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Figure 7: Half-life and synthesis rate distribution of transcript classes. (A) Distribution of
synthesis rates for different transcript classes. (B) Distribution of half-lives for different transcript
classes. Data information: Box limits are the first and third quartiles, the band inside the box is
the median. The ends of the whiskers extend the box by 1.5 times the interquartile range.
11 TT-seq uncovers many immediate response genes
We next analyzed changes in transcript coverage upon T-cell stimulation after in-
tegrating reads over transcribed units at different time points. When we compared
time points 5, 10, and 15 min with time point 0 min, RNA-seq data did not reveal
any significant (FC > 2, adjusted P -value < 0.05, Methods Section 9.7) changes. In
contrast, TT-seq uncovered hundreds of newly synthesized transcripts with signif-
icantly changed signals already after 5 min, and thousands of changed transcripts
after 15 min following stimulation (FC > 2, adjusted P -value < 0.05, Section 9.7,
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Figure 8: TT-seq captures transcriptional changes after T-cell stimulation. (A) TT-seq signal for
statistically significant differentially expressed transcripts after 5, 10, and 15 minutes compared to
time point 0 min, before cell stimulation. Significantly differentially expressed genes are indicated
by black points. The numbers in the plots correspond to the numbers of significantly up/down-
regulated transcripts at each time point. The vertical orange lines indicate the fold change cutoff
of 2, and the horizontal orange line shows the P -value cutoff of 0.05. (B) Sense and antisense
transcription mapped with TT-seq at the FOS gene and its annotated upstream enhancer. The
rectangles with arrows indicate transcripts annotated in this study.
Figure 8A, Tables 3 and 4). These results show that transcription activity in T-cells
changes immediately upon stimulation and that TT-seq captures transcriptional up-
and down-regulation with great sensitivity long before changes in RNA levels are
detected by RNA-seq.
Out of a total of 3,744 transcripts that showed significantly changed synthe-
sis 15 min after stimulation, 638 were mRNAs, and 2,986 were ncRNAs, including
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120 lincRNAs (Tables 3 and 4). Many up-regulated mRNAs encode known marker
proteins of T-cell activation, such as FOS, FOSB, JUN, JUNB and CD69. Other
up-regulated mRNAs stemmed from known immediate-early response genes, such as
transcription factors EGR1, EGR2, EGR3, and NR4A1, and the stem cell identity
factor KLF4. However, the majority of the up-regulated mRNAs that we detected
had not been described in association with T-cell stimulation. Of the 638 differ-
entially expressed mRNAs, only &20% were known to be involved in T-cell acti-
vation (Cheadle et al. 2005; Diehn et al. 2002; Ellisen et al. 2001). Amongst the
newly detected up-regulated genes were those that encode GPR50, KLF4, DUSP1,
PPP1R15A, MASP2, and RGCC proteins that are involved in processes, such as
MAPK signaling or other signaling pathways, the immune response, or the response
to stimuli. Thus, the high sensitivity of TT-seq can uncover new target genes even
in very well-studied systems.
mRNAs lincRNAs ncRNAs (eRNAs) Total
5 min 29 12 206 (135) 247
10 min 132 42 1,195 (594) 1,369
15 min 311 78 2,058 (897) 2,447
Table 3: Number of up-regulated transcripts per class and time point after activation. The
number of ncRNAs includes the number of eRNAs, which is shown in parenthesis.
mRNAs lincRNAs ncRNAs (eRNAs) Total
5 min 9 1 99 (70) 109
10 min 42 16 523 (359) 581
15 min 327 42 928 (629) 1,297
Table 4: Number of down-regulated transcripts per class and time point after activation. The
number of ncRNAs includes the number of eRNAs, which is shown in parenthesis.
12 Defining the dynamic landscape of transcribed
enhancers
The vast majority of transcripts with significantly changed synthesis after stimula-
tion were ncRNAs. When we investigated the TT-seq coverage at known enhancers,
42
we observed increasing RNA synthesis, showing that we could monitor eRNA pro-
duction at transcribed enhancers such as the one at the FOS locus (Figure 8B).
Within 15 min after stimulation, eRNA synthesis at this locus increased about
160-fold, whereas synthesis of FOS mRNA increased about 40-fold (Figure 8B).
The TT-seq coverage profiles also immediately revealed bidirectional transcription
at both the promoter and a known enhancer at the FOS locus. Thus, enhancer
transcription is very well captured by TT-seq, encouraging us to fully describe the
landscape of transcribed enhancers and its changes during T-cell stimulation.
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Figure 9: Example of eRNA identification using GenoSTAN. (A) Shown are the DNAse hy-
persensitivity signal (DHS) from ENCODE (top, black marks), the GenoSTAN enhancer states
(violet colored) obtained from from 14 Roadmap Epigenomics T-cell lines (middle), and the ob-
tained transcript annotation (bottom) for a region on chromosome 11. (B) As in A for a region
on chromosome 17.
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To select putative eRNAs from our annotated 12,673 ncRNAs, we used our
recent GenoSTAN annotation of chromatin states in genomes of 14 T-cell lines,
which is based on the integration of publicly available chromatin marks and DNA
accessibility data (Zacher et al. 2017). We compared all ncRNAs with all enhancer
states from T-cells (Zacher et al. 2017) (Figure 9). This resulted in 5,616 (44%)
ncRNAs that overlapped with enhancer states either with their transcribed region
or with the region 1,000 bp upstream, and were therefore classified as putative
eRNAs (Figure 10A).
13 Immediate, nucleosome-depleted enhancers
Out of a total of 50,810 annotated T-cell enhancer states, 7,865 produced eRNAs in
our cell line and under our conditions that we could detect. The obtained putative
5,616 eRNAs showed a similar length distribution as the remaining 7,057 ncRNAs
(Figure 10B, Appendix Figure A3A), but had shorter half-lives (Figure 10C, Ap-
pendix Figure A3B), reflecting the known unstable nature of eRNAs. The sets of
putative active eRNAs (applying the same cutoff as for the transcriptome annota-
tion, RPK   16.5) comprises more than 5,000 actively transcribed eRNAs at each
time point (Figure 10A). For a large fraction of eRNAs (29%) we observed signifi-
cant changes in their synthesis during the time course compared to the initial time
point (Section 9.7), showing that eRNA transcription is highly regulated.
Consistent with the chromatin state annotation of enhancers, the putative eRNAs
were flanked by a region of high DNase hypersensitivity (The ENCODE Project
Consortium 2012) immediately upstream, which was not the case for the remaining
ncRNAs (Figure 10D). In addition, the region 250 bp upstream of the eRNA TSS
was significantly enriched for binding sites of transcription factors that act during
T-cell activation, namely EGR1, EGR2, ERG3, JUNB, REL, FOSL2, FOS (odds
ratios 6.8, 4.3, 3.8, 1.6, 1.6, 1.5, and 1.3, respectively, Section 9.8), compared to
other ncRNA upstream sequences (Figure 10E). This strongly indicates that our
set of putative eRNAs represents transcripts originating from enhancers that are
relevant for the T-cell response. Taken together, TT-seq can define the landscape
of actively transcribed enhancers, and its changes during T-cell stimulation.
44
Odds Ratio
12 10 8 6 4 2 0
Odds Ratio=1
Odds Ratio=2 FOS*
FOSL2*
REL*
JUNB*
EGR3*
EGR2*
EGR1*
RFX2*
ETV2*
RFX3*
Proportion of transcribed 
enhancers
with TF binding site in %
0 2 4 6 8 10
B
D
A C
E
0.2
0.5
1.0
2.0
5.0
10.0
20.0
50.0
H
a
lf 
lif
e
 [
m
in
]
P=1.37e−273
other
ncRNAs
eRNAs
−1000 −500 TSS 500 1000
0
5
1
0
1
5
eRNAs
other ncRNAs
Distance from Transcription Start Site
M
e
a
n
 D
H
S
 c
o
ve
ra
g
e
86 bp
eRNAs
other ncRNAs
Type of ncRNAs
44%
5616
56%
7057
12,6730
 m
in
: 5,130
5
 m
in
: 5,262
1
0
 m
in
: 5,467
1
5
 m
in
: 5,596
other
ncRNAs
eRNAs
0.2
0.5
1.0
2.0
5.0
10.0
L
e
n
g
th
 [
kb
]
P=8.95e−64
Figure 10: Characteristics of transcribed enhancers. (A) Distribution of identified eRNAs among
ncRNAs annotated based on TT-seq signal. The outer circle segments show the number of actively
transcribed eRNAs (RPK   16.5) at each time point. (B) Length distribution of eRNAs and other
ncRNAs. The P -value was derived by two-sided Mann-Whitney U test. Box limits are the first
and third quartiles, the band inside the box is the median. The ends of the whiskers extend the
box by 1.5 times the interquartile range. (C) Half-life distribution of eRNAs and other ncRNAs.
The P -value was derived by two-sided Mann-Whitney U test. Box limits are the first and third
quartiles, the band inside the box is the median. The ends of the whiskers extend the box by 1.5
times the interquartile range. (D) Average DNase hypersensitivity sites (DHS) signal at the TSS
of eRNAs and other ncRNAs. (E) Motif enrichment in the 250 bp upstream sequences of eRNA
versus other ncRNAs. Displayed are only motifs of upregulated TFs with odds ratio > 1.2 and
P -value < 0.05. The stars indicate TFs with statistical significant enrichment upon eRNAs after
multiple testing correction (Benjamini-Hochberg method, FDR < 0.05).
14 Transcription from promoters and enhancers is
correlated and distance-dependent
We next paired eRNAs and mRNAs that localized within insulated neighborhoods
(Figure 11A) that were defined with a combination of cohesin ChIA-PET and CTCF
ChIP-seq profiling performed in the Jurkat cell line (Hnisz et al. 2016b). After
removing pairs of upstream divergent (1 kb upstream of sense TSS) and conver-
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gent (1 kb downstream of sense TSS) transcripts and their bidirectional promoters,
we obtained a total of 6,896 eRNA-mRNA pairs that represent putative enhancer-
promoter pairs. These pairs contained 2,454 transcribed enhancers and 2,520 pro-
moters. On average there were 1.3 transcribed enhancers and 1.5 promoters located
within an insulated region (Figure 12A). The median transcribed enhancer-promoter
distance within these pairs was 117 kb, with 52% of all paired transcribed enhancers
residing within +/- 50 kb from their closest paired promoter (Figure 11B). There
was no preference for eRNA orientation with respect to the mRNA orientation (Fig-
ure 12B). Due to the small size of the insulated neighborhoods and our conservative
pairing, most transcribed enhancers (56%) and most promoters (72%) remained un-
paired. The paired transcribed enhancers engaged on average with 2.8 promoters,
whereas paired promoters engaged on average with 2.7 enhancers (Figure 11C).
We found that changes in RNA synthesis over time correlated very well be-
tween transcribed enhancers and their paired promoters (Figure 11D, Section 9.9).
When we shuffled the transcribed enhancers and promoters and paired them ran-
domly, irrespective of insulated neighborhoods, the correlation dropped (Figure 12C,
P -value=9.99e-4). Moreover, the correlation was higher for transcribed enhancers
located less than 10 kb from their paired promoter (‘proximal enhancers’) than for
those located further apart (‘distal enhancers’) (Figure 11D). This indicates that
enhancer transcription decreases with increasing distance from the activated tar-
get promoter, consistent with the observation that interacting enhancers tend to be
close to their promoters (Dekker et al. 2013; He et al. 2014).
The distance between transcribed enhancer-promoter pairs is limited by the size
of the insulated neighborhoods, but it is generally much shorter (P -value < 2.2e-16,
Figures 12D and E). Pairing within insulated neighborhoods leads to higher correla-
tions than pairing every promoter with it’s closest transcribed enhancer (Appendix
Figure A4). There is no relationship between the distance and the correlation over
time between closest transcribed enhancer-promoter pairs (Spearman correlation
 0.03, Appendix Figure A5). When we splitted up the closest pairs dependent on
their location within the same insulated neighborhood, the pairs within the same
loop showed a higher correlation (P -value=0.00121, Appendix Figure A6).
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These results indicate that the correlation in changes of RNA synthesis from
transcribed enhancers and promoters depends on both genomic distance and location
within insulated neighborhoods.
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Figure 11: Pairings of transcribed enhancers with promoters. (A) Schematic of transcribed
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Figure 12: Details on transcribed enhancer-promoter pairs. (A) Number of transcribed en-
hancers and transcribed promoters per ChIA-PET defined insulated neighborhood. Count values
were jittered for visualization purposes. (B) Location and orientation of transcribed enhancers
with respect to their paired target gene TSS. Negative values indicate the transcribed enhancer
location upstream of the promoter TSS, positive values downstream of the promoter TSS. Up-
per histogram: Distance distribution for transcribed enhancers on the same (‘sense’) strand as
their target promoter. Lower histogram: Distance distribution for transcribed enhancers on the
opposite, antisense strand. Figure legend continued on next page.
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Figure 12: (C) Distribution of the Pearson correlation between observed TT-seq signal at tran-
scribed enhancers and promoters for the enhancer-promoter pairs derived here (where both eRNA
and mRNA change significantly between 0 min and 15 min timepoints; red line) and for 1,000
randomly shuffled enhancer-promoter pairs (grey lines). The colored profile indicates the quan-
tiles (5-95% of the data) with the black median line and the grey 25% and 75% quantile lines.
Observed correlations are enriched for positive correlations (right peak) and depleted for negative
correlations (left peak). (D) Distribution of insulated neighborhood size by Cohesin-ChIA-PET
and CTCF-ChIP-seq. The median size of an insulated neighborhood was 255 kb. (E) Distance
of transcribed enhancer-promoter pairs versus the size of the corresponding insulated neighbor-
hood. The lines indicate the size of the insulated neighborhood (by which the distance is bound by
definition), and a third of the size of the insulated neighborhood (which is the expected distance
between tow randomly drawn positions in a neighborhood). The P -value was derived by a one-
sided Mann-Whitney U test. For visualization purposes, 127 points with insulated neighborhood
size > 2,000 kb are not shown.
15 Rapid up- and down-regulation via promoter-
proximal elements
Our results raise the question how transcription can be activated from promoters
without paired enhancers. It is known that promoters may contain proximal bind-
ing sites for transcriptional activators such as AP-1, a heterodimer of FOS and JUN
proteins, that is induced upon T-cell stimulation. Indeed we found that upregulated
but unpaired promoters were enriched for AP-1 binding sites (TGACTCA) in the
promoter-proximal region 500-100 bp upstream of the TSS for mRNA transcription,
compared to upregulated and paired mRNAs (odds ratio 2.24, P -value 0.031, Sec-
tion 9.8). This shows that TT-seq can be used to disentangle promoter-based from
enhancer-based activation of gene expression.
TT-seq also revealed a large number of downregulated genes upon T-cell stim-
ulation, as captured by ceasing RNA synthesis. Such rapid downregulation cannot
be observed by RNA-seq, due to the stability of most mRNAs. When we investi-
gated sequence motifs for unpaired downregulated mRNAs compared to unpaired
upregulated mRNAs, we did not find enriched motifs that are known to bind tran-
scriptional repressors, but consistently found them to be depleted of binding sites
for the transcriptional activator AP-1 in the region 500-100 bp upstream of the TSS
(odds ratio 0.51, P -value 0.022, Section 9.8). Together these observations show that
TT-seq is ideally suited to detect down-regulated genes and are consistent with the
view that rapid gene regulation can be mediated by the promoter-proximal region.
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16 Transcription from enhancers and promoters oc-
curs simultaneously
We next investigated whether there are temporal differences in the onset of tran-
scriptional changes between enhancers and promoters. In particular, we wished to
find out whether enhancers were transcribed before their paired promoters. To this
end, we selected pairs where the transcriptional change 15 min after stimulation
for both the transcribed enhancer and the promoter in the TT-seq samples was at
least two-fold increased (‘up-regulated pairs’) or two-fold decreased (‘down-regulated
pairs’) and significant (FDR < 0.05). This selection ensures that both the promoters
and the transcribed enhancer have been activated during the time course allowing
to probe the relative timing of activation. The TT-seq data clearly showed that
changes in RNA synthesis occurred simultaneously at paired transcribed enhancers
and promoters, both for up- and down-regulated pairs, at the temporal resolution
of our data and within a given variation (Figure 13). This shows that for an imme-
diate transcription response the changes in RNA synthesis for enhancers and their
paired promoters occur simultaneously, provided our current temporal resolution
(Figures 13A and C).
In contrast, our RNA-seq data suggested that an increase in enhancer tran-
scription preceded mRNA transcription for up-regulated pairs (Figures 13B and D).
However, this does not mean that eRNA synthesis changes more rapidly than mRNA
synthesis. Instead, the half-life of eRNAs is around two orders of magnitude shorter
than that of mRNAs (Rabani et al. 2014; Schwalb et al. 2016), and this renders
eRNA levels very sensitive to changes in their synthesis (Figure 7). Also, RNA-seq
cannot detect changes in down-regulated pairs because mRNAs have long half-lives
in the range of hours (Rabani et al. 2014; Schwalb et al. 2016), and therefore, a
rapid shut-down in RNA synthesis does not change mRNA levels when monitored
within minutes.
Taken together, TT-seq enables monitoring rapid changes in both eRNA and
mRNA synthesis that cannot be detected by RNA-seq in an unbiased manner.
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Figure 13: Temporal changes in enhancer and promoter transcription. Figure legend continued
on next page.
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Figure 13: Temporal changes in enhancer and promoter transcription. (A) Development of
TT-seq signal over time after T-cell stimulation for paired promoters and enhancers (n=131) that
are both significantly upregulated (FC   2, FDR  0.05) 15 min after stimulation (over the whole
eRNA/ the first 2,200 bp of the mRNA). The y-axis shows the normalized read counts over the
whole transcribed enhancer region (violet) and the first 2,200 bp (average length of eRNA) of
the paired mRNA (red). The black line indicates the median. (B) As in panel A but using
RNA-seq read counts. (C) TT-seq signal change as in panel A but for paired promoters and
enhancers (n=128) that are both significantly downregulated (FC  1/2, FDR  0.05) 15 min
after stimulation. (D) As in panel C but using RNA-seq read counts. Data information: Box
limits are the first and third quartiles, the band inside the box is the median. The ends of the
whiskers extend the box by 1.5 times the interquartile range.
17 Discussion
Here, we used TT-seq to monitor a very rapid transcription response in human
T-cells, and show that TT-seq can globally detect very short-lived transcripts such
as eRNAs in a highly dynamic system at high temporal resolution. We demonstrate
that TT-seq is suitable for annotating potential eRNAs and quantifying transcrip-
tional changes very early after stimulation and thus provides insights into gene
regulation, activation, and enhancer identity. Our results have implications for un-
derstanding the T-cell response, the temporal sequence of enhancer and promoter
transcription during gene activation, the nature of functional enhancer-promoter
pairing, and the design of future studies of transcription regulation in human cells.
First, our results provide new insights into the immediate T-cell response. TT-seq
enabled us to detect immediate changes in the synthesis of thousands of transcripts.
These RNAs included most of the transcripts known to be altered during T-cell stim-
ulation, confirming known studies. We also found, however, many new mRNAs and
ncRNAs that show altered synthesis upon T-cell stimulation. Many of these have
functions in signaling pathways (PPP1R15A, KLF4, ARC ), the response to stimuli
(KLF4, GPR50, DUSP1, MASP2 ), or have catalytic activities (DUSP1, MASP2 ).
Our results of immediate transcriptional changes confirm very early single-locus ra-
diolabeled nuclear run-on studies of T-cell activation (Greenberg et al. 1984). Our
results thus extend and complement previous genome-wide studies of the T-cell re-
sponse (Cheadle et al. 2005; Diehn et al. 2002; Ellisen et al. 2001), and help to more
generally understand very early transcriptional responses.
Our work also identifies and characterizes eRNAs based on their synthesis, thereby
mapping transcribed enhancers. We show that eRNA-producing enhancers can be
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paired with their target promoters by taking advantage of previously published
datasets on insulated neighborhoods (Hnisz et al. 2016b) and chromatin states (Zacher
et al. 2017). This yields enhancer-promoter pairs with highly correlated temporal
changes in RNA synthesis. These results are consistent with the idea that eRNA
transcription is a very sensitive and good proxy for the activity of enhancers with
respect to target gene activation (Hah et al. 2015). One limitation of the method,
however, relates to the inability of TT-seq to detect intronic eRNAs in sense direc-
tion of mRNA transcription; however, only a small fraction of enhancers is missed
this way.
The classification of non-coding RNAs remains challenging. The previous defini-
tions of lincRNAs (long, stable, spliced, polyadenylated) and eRNAs (short, short-
lived, transcribed from enhancer element) do not always allow for a clear distinction
between them (Paralkar et al. 2016). Here we decided to exclude the GENCODE
class of ‘lincRNAs’ from our eRNA set because these are evolutionary conserved
and less likely to be cell type-specific enhancer transcripts. Due to the low number
of transcripts overlapping GENCODE-annotated lincRNAs (n=590), we are not ex-
cluding many potential eRNAs, although some lincRNAs may stem from enhancers.
Our results also provide evidence that enhancer and promoter transcription can
occur simultaneously during immediate gene activation. Our observations are de-
rived from a single biological process with very fast response kinetics. Previous
studies have observed that enhancer transcription precedes transcription from pro-
moters, although in some cases, evidence for simultaneous transcription was also
obtained (Arner et al. 2015; De Santa et al. 2010; Kaikkonen et al. 2013; Schaukow-
itch et al. 2014). These differences can to some extent be explained by the high
sensitivity and temporal resolution of TT-seq, but may also reflect differences in
the cellular responses monitored. Whereas we focused here on the immediate T-cell
response that occurs within minutes, published work generally analyzed responses
after hours, and these require changes in chromatin at enhancers (Kaikkonen et al.
2013). Changes in chromatin could lead to a time lag between enhancer and pro-
moter transcription and likely do not occur during the immediate response we inves-
tigated here because immediate-early genes responding within minutes are poised for
gene activation, and chromatin is in a pre-open state (Byun et al. 2009; Tullai et al.
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2007). Similarly, enhancers are primed for activity and are DNase I hypersensitive
and modified with H3K4me1 (Wang et al. 2015).
Most importantly, our results demonstrate that TT-seq is an easy-to-use tool that
is ideally suited to monitor rapid changes in the genomic landscape of transcribed
enhancers and gene transcription in a non-perturbing manner in vivo. In addition to
its high sensitivity and high temporal resolution, TT-seq is uniquely suited to detect
immediate down-regulation of genes, as it informs on drops in RNA synthesis when
the mRNA product is long-lived and will give a signal in RNA-seq even at time points
when transcription has been shut off for a long time already. In addition, TT-seq
will map only those enhancers that produce eRNA at a certain time, providing
apparently active enhancers rather than a list of all chromatin regions with enhancer
signatures that may stem from past enhancer transcription events. TT-seq therefore
facilitates the pairing of enhancers with putative target promoters. In the future,
the application of TT-seq to other human cells, signaling and differentiation events,
is expected to provide novel biological insights into fundamental changes in gene
regulatory programs.
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Part IV
Further Contributions
In this section, I present additional work from collaborations that has already been
published. All of these studies are based on TT-seq and 4tU-seq experiments. They
are briefly explained and summarized in the following.
18 TT-seq measures transcription rates for tran-
sient RNAs
The results presented in this section have been published in:
TT-seq maps the human transient transcriptome
B. Schwalb*, M. Michel*, B. Zacher*, K. Frühauf, C. Demel, A. Tresch, J. Gagneur, and
P. Cramer
Science (2016), 352(6290), 1225-1228.
The full article with supplementary materials can be found at http: // science.
sciencemag. org/ content/ 352/ 6290/ 1225 .
Contribution: I established the spike-in normalization method (presented in Sec-
tion 8), which was first applied in this study.
18.1 Introduction
Transcription of eukaryotic genomes produces protein-coding mRNAs and many
non-coding RNAs (ncRNAs), including enhancer RNAs (eRNAs) that stem from
regulatory elements (Andersson et al. 2014; Jensen et al. 2013). Most ncRNAs are
rapidly degraded, difficult to detect, and generally impossible to map in their full
length. Comprehensive and complete mapping of such transient RNAs, however, is
required to understand how genomes are regulated and how RNA fate is controlled.
We developed transient transcriptome sequencing (TT-seq), a protocol that uni-
formly maps the entire range of RNA-producing units and estimates rates of RNA
synthesis and degradation.
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Figure 14: Estimated synthesis rates, half-lives, and predicted structure. Adapted from (Schwalb
et al. 2016). Reprinted with permisson from AAAS. Figure legend on continued on page.
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Figure 14: Estimated synthesis rates, half-lives, and predicted structure. (A) Distribution of
synthesis rates per transcript class. Black bars represent the median, boxes represent upper and
lower quartile, and whiskers represent 1.5 times the interquartile range. (B) Estimated RNA half-
lives for different transcript classes. (C) Distribution of half-lives of different transcript classes
depending on whether they are predicted to be structured or not (+, -; (Washietl et al. 2005)).
(D) Distribution of the minimum free energy in the first 1000 nucleotides per transcript class. (E)
Distribution of percentage of structured RNA in different transcript classes.
18.2 Results
Kinetic modeling of TT-seq and RNA-seq data (see also Section 8) enabled us to
estimate rates of RNA synthesis and degradation (Figures 14A and B). We estimated
rates of phosphodiester bond formation or breakage at each transcribed position and
averaged these within TUs, thus obtaining estimates of relative transcription rates
and RNA stabilities. We found that mRNAs and lncRNAs had the highest synthesis
rates and longest half-lives. We determined a median mRNA half-life of &50 min,
compared to a previous estimate of &139 min (Rabani et al. 2014). Other transcript
classes had low synthesis rates and short half-lives, explaining why short ncRNAs
are difficult to detect. eRNAs had half-lives of a few minutes, consistent with prior
data (Rabani et al. 2014).
Short RNA half-lives correlated with a lack of secondary structure (Figure 14C).
The folding energy of eRNAs was comparable to the genomic background level (Fig-
ure 14D), and only 10% of their sequence was predicted to be structured, compared
with 52% in mRNAs (Figure 14E).
18.3 Summary
Application of TT-seq to human K562 cells recovers stable mRNAs and long inter-
genic non-coding RNAs, and additionally maps over 10,000 transient RNAs, includ-
ing enhancer RNAs, antisense RNAs, and promoter-associated RNAs, both conver-
gent and upstream antisense RNAs. TT-seq analysis shows that enhancer RNAs
are short-lived and lack secondary structure.
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19 Quantification of Schizosaccharomyces pombe
RNA metabolism
The results presented in this section have been published in:
Determinants of RNA metabolism in the Schizosaccharomyces pombe genome
P. Eser*, L. Wachutka*, K.C. Maier, C. Demel, M. Boroni, S. Iyer, P. Cramer, and J. Gagneur
Molecular Systems Biology (2016), 12(2), 857.
The full article with supplementary materials can be found at http: // msb. embopress.
org/ content/ 12/ 2/ 857 .
Contribution: I conducted initial analyses and provided count matrices for all rel-
evant features, namely exons, introns, exon-intron junctions, and intron-exon junc-
tions, that are the basis for fitting the kinetic model.
19.1 Introduction
Gene expression can be regulated at each stage of RNA metabolism, during RNA
synthesis, splicing, and degradation. The rates of both RNA degradation and splic-
ing contribute to the time required for reaching mature RNA steady-state levels
following transcriptional responses (Jeffares et al. 2008; Rabani et al. 2014).
The fission yeast Schizosaccharomyces pombe (S. pombe) is an attractive model
organism to study eukaryotic RNA metabolism. S. pombe shares important gene
expression mechanisms with higher eukaryotes, including splicing. To cover the
typical range of synthesis, splicing, and degradation rates, cells in a steady-state
culture were harvested after 2, 4, 6, 8, and 10 min following 4tU addition. Moreover,
a matching total RNA-seq was performed after 10 min labeling to control for the
slower doubling time in the presence of 4tU (285 min versus 180 min).
19.2 Results
The data contained many reads that stemmed from intronic sequences and reads
comprising exon–intron junctions, showing that 4tU-seq captured short-lived pre-
cursor RNA transcripts. These reads from unspliced RNA gradually ceased during
the time course (Figure 15A and B), indicating that the kinetics of RNA splicing
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may be inferred from the data.
To globally estimate rates of RNA synthesis, splicing, and degradation, we used
a first-order kinetic model with constant rates that describes the amount of labeled
RNA as a function of time (Figure 15C). We modeled splicing of individual introns,
where splicing refers to the overall process of removing the intron and joining the
two flanking exons. The model was fit to every splice junction using the counts
of spliced and unspliced junction reads (Figure 15C and D). We included in the
model scaling factors that account for variations in sequencing depth, an overall
increase of the labeled RNA fraction, cross-contamination of unlabeled RNA, and
4tU label incorporation efficiency. The model was fitted using maximum likelihood
and assuming negative binomial distribution to cope with overdispersion of read
counts (Anders et al. 2010; Robinson et al. 2010). Our method yields absolute
splicing and degradation rates, but provides synthesis rates up to a scaling factor
common to all TUs. Absolute synthesis rates were obtained by scaling all values so
that the median steady-state level of ORF-TUs matches the known median of 2.4
mRNAs per cell (Marguerat et al. 2012). To facilitate comparisons of the obtained
RNA metabolic rates, we present the synthesis rate as the average time elapsed
between the production of two transcripts in a single cell (‘synthesis time’), the
degradation rate as the time needed to degrade half of the mature RNAs (‘half-
life’), and the splicing rate as the time to process half of the precursor RNA junction
(‘splicing time’). The synthesis times and half-lives inferred from distinct splice
junctions of the same TU agreed well, demonstrating the robustness of our approach
(Spearman rank correlation = 0.44 for synthesis time, P < 2⇥ 10 16 and Spearman
rank correlation = 0.79 for half- life, P < 2⇥ 10 16, Figure 15E)
19.3 Summary
By combining metabolically labeled RNA profiling at high temporal resolution with
computational kinetic modeling, we obtained in vivo RNA synthesis, splicing, and
degradation rates across an entire eukaryotic genome, providing insights into RNA
metabolism.
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Figure 15: Estimating RNA processing rates using labeled RNA time series. (A) Per-base
coverage (gray tracks) in a logarithmic scale of 4tU-seq samples at 2, 4, 6, 8, and 10 min. labeling
and for one RNA-seq sample (i.e., steady state) along the UTRs (white boxes), the exons (dark
boxes), and the introns (lines) of the TU encoding cdc2. (B) Distribution of sequencing depth
normalized unspliced junction read counts (top panel) and normalized spliced junction read counts
(lower panel) for the complete 4tU-seq time series and the steady-state RNA-seq samples. (C)
Schema of the junction first-order kinetics model. Each splice junction is modeled individually,
assuming constant synthesis time, splicing time and half-life. Unspliced junction reads (blue) are
specific to the precursor RNA and spliced junction reads (red) are specific to the mature RNA. (D)
Observed (circles) and fitted (lines) splice junction counts for the first intron of TU.0597 (php3 ).
Unspliced (blue) and spliced (red) normalized counts (y-axis) are shown for all 4tU-seq samples
and the steady-state sample (x-axis). (E) Half-life estimated from the first (x-axis) versus the
second (y-axis) splice junction on TUs with two or more introns.
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20 Spt5 is required for a normal rate of RNA syn-
thesis
The results presented in this section have been published in:
Spt5 plays vital roles in the control of sense and antisense transcription elongation
A. Shetty*, S.P. Kallgren*, C. Demel, K.C. Maier, D. Spatt, B.H. Alver, P. Cramer, P.J. Park,
and F. Winston
Molecular Cell (2017), 66, 1-12.
The full article with supplementary materials can be found at http: // www. cell.
com/ molecular-cell/ fulltext/ S1097-2765( 17) 30160-0 . Relevant methods for
the results presented here are given in Section 26.
Contribution: I analyzed all 4tU-seq data generated for this project.
20.1 Introduction
In eukaryotes, Spt5 is an integral and essential part of the Pol II elongation com-
plex (Mayer et al. 2010; Rahl et al. 2010). While Spt5 has been extensively studied,
surprisingly little has been done to test its role as a positive transcription elonga-
tion factor genome-wide. To address the genome-wide role of Spt5 in transcription,
we have comprehensively analyzed the effects of Spt5 depletion on transcription
genome-wide in the model organism Schizosaccharomyces pombe (S. pombe). We
constructed a S. pombe strain that allows for efficient, auxin-inducible degradation
of Spt5. Using this system, we were able to efficiently deplete Spt5 genome-wide,
while maintaining cell viability. We then measured the level of Pol II across the
S. pombe genome using ChIP-seq and NET-seq, comparing cells before and after
Spt5 depletion. Our results showed that after Spt5 depletion, there was a globally
reduced level of Pol II across transcribed regions. Importantly, the distribution of
Pol II across genes also changed, with an accumulation over the first &500 bp of
genes, followed by a decreased level of Pol II downstream.
20.2 Results
To gain greater insight into the changes in elongation when Spt5 is depleted, we mon-
itored cellular RNA synthesis before and after Spt5 depletion by metabolic labeling
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with 4tU (Miller et al. 2011) and normalization with RNA spike-in probes (Sec-
tion 8). The 4tU-seq results showed greatly decreased RNA synthesis rates genome-
wide in the Spt5-depleted cells, consistent with a general elongation-stimulatory
activity for Spt5 (Figure 16A). We observed a uniform decrease in RNA synthe-
sis activity across transcription units (Figure 16B) and antisense of transcription
units (Figure 16C), suggesting that the overall rate of transcription is decreased
when Spt5 is depleted. Taken together with our ChIP-seq and NET-seq results,
these findings suggest that Spt5 is required for a normal rate of transcription by
Pol II in order to elongate past a site or barrier at a position within 500 bp from
the transcription start site (TSS), possibly a nucleosome or an Spt5-dependent tran-
scription checkpoint (Hartzog et al. 1998; Lidschreiber et al. 2013; Viladevall et al.
2009).
Figure 16: Spt5 is required for a normal rate of transcription genome-wide. (A) The scatter-
plot shows new RNA synthesis measured by 4tU-seq in Spt5-depleted versus non-depleted cells.
Each point corresponds to the spike-in normalized signal from one transcript for merged replicate
experiments. (B) The heatmap shows the log2 ratio of the spike-in normalized 4tU-seq signal in
Spt5-depeleted versus non-depleted cells. Genes are sorted by length and aligned by their TSS.
The TSS and pA-site are indicated by the solid black lines. (C) The heatmap depicts the 4tU-seq
log2-fold change in signal obtained for the synthesis of antisense transcripts across transcribed
regions in Spt5-depleted compared to non-depleted cells, analogous to (B).
20.3 Summary
Spt5 is an essential and conserved factor that functions in transcription and co-
transcriptional processes. However, many aspects of the requirement for Spt5 in
transcription are poorly understood. We have analyzed the consequences of Spt5
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depletion in Schizosaccharomyces pombe using four genome-wide approaches. Our
results demonstrate that Spt5 is crucial for a normal rate of RNA synthesis and
distribution of Pol II over transcription units. In the absence of Spt5, Pol II local-
ization changes dramatically, with reduced levels and a relative accumulation over
the first &500 bp, suggesting that Spt5 is required for transcription past a barrier.
Spt5 depletion also results in widespread antisense transcription initiating within
this barrier region. Deletions of this region alter the distribution of Pol II on the
sense strand, suggesting that the barrier observed after Spt5 depletion is normally
a site at which Spt5 stimulates elongation. Our results reveal a global requirement
for Spt5 in transcription elongation.
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Part V
Future Perspectives
The newly developed TT-seq protocol is a highly-sensitive method to investigate
the transcription of transient RNAs. These technological and experimental ad-
vances pose new challenges to the field of computational biology, both in terms of
mathematical models and analysis of this data.
To infer correct synthesis and degradation rates, the relative ratio of 4sU/4tU-
labeled RNA to the total RNA in the sample has to be determined. The method
presented in this thesis provides the theoretical basis to normalize 4sU-labeled and
total RNA-seq samples relative to each other. This is accomplished with a GLM
that is fit to read counts from artificial spike-ins, which can be labeled in vitro.
Additionally, the use of spike-ins allows to observe global expression changes and to
adjust for them.
The normalization scheme can be applied to genome-wide TT-seq and RNA-seq
data sets and allows to infer synthesis and degradation rates for all transcription
products at base-pair resolution.
The sensitivity of TT-seq facilitates the observation of newly synthesized tran-
scription products. This led to the discovery of many unannotated transcripts (Michel
et al. 2017; Schwalb et al. 2016). With the help of additional datasets, cell line-
specific enhancer RNAs (eRNAs) can be identified and paired with their promot-
ers (Michel et al. 2017). Knowing enhancers and their expression patterns is crucial
to understand cellular regulatory mechanisms.
21 Extensions for the mathematical model
The model presented in Section 8 could be extended to also account for dynamic
changes in the total RNA levels in the cell. In cases where the steady-state assump-
tion does not hold true, synthesis and degradation rates are not constant and need
to be estimated independently for time points in a dynamic time course experiment.
One approximation could be made in the case of very long time courses. Then, it
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can be assumed that for a few distinct time points in a long time course, synthe-
sis and degradation rates within the short (5 minute) labeling time are constant.
Therefore, the model presented in this thesis can be applied to estimate time-specific
synthesis and degradation rates. Otherwise, time-specific synthesis and degradation
rates need to be estimated. The model can also be extended to include the doubling
time of cells, which affects the RNA levels in the cell.
22 Biological applications
The TT-seq method and its sensitivity to detect transient RNAs makes it an ideal
tool to calculate genome-wide rates of transcription kinetics in an unperturbed man-
ner. The presented normalization scheme allows the comparison of different biolog-
ical samples on a global scale. Therefore, TT-seq and the presented mathematical
method to calculate synthesis rates and half-lives can be used to address various
biological questions. I will discuss some of them here in detail:
22.1 Human splicing rates
Splicing of introns contributes to the complexity of eukaryotic organisms. In hu-
man, &95% of genes undergo alternative splicing (Pan et al. 2008). The short half-
live of introns complicates measuring RNA splicing rates. In vitro, transcripts are
spliced within 15-60 min after their synthesis (Das et al. 2006). Single-molecule as-
says have shown that splicing rates in vivo are much faster. Estimated splicing rates
range from 30s to 10 min (Carrillo Oesterreich et al. 2011). They have been deter-
mined by various assays, such as direct visualization by electron microscopy (Beyer
et al. 1988), reverse transcription with PCR amplification (RT-PCR) (Kessler et al.
1993), observing flourescence of single pre-mRNAs by microscopy (Martin et al.
2013), or transcription arrest followed by quantitative RT-PCR (Singh et al. 2009).
Most of the approaches used for splicing rate estimation, however, are conducted in
vitro or are limited to single, long genes. The application of TT-seq can result in
genome-wide, in vivo splicing rates, independent of gene lengths. Short, progressive
RNA labeling followed by TT-seq can be used to determine robust splicing rates for
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individual junctions as in S. pombe (Eser et al. 2016). The estimation of degrada-
tion rates per phosphodiester bond allows to individually determine splicing rates
for donor and acceptor sites. Varying rates for donor and acceptor splice sites can
reveal alternative splicing events (Wachutka et al. 2016). The obtained splicing rates
could be correlated to the position of the intron within the gene and with nearby
sequence motifs (Eser et al. 2016).
It is also possible to quantify the effects of specific splicing inhibitors, such as
pladienolide (Pla-B) (Kotake et al. 2007). The additional use of artifical spike-
ins and application of the spike-in normalization presented in this thesis allows to
compare the splicing effects of inhibitor-treated cells relative to wild-type cells.
22.2 Cellular differentiation
Cellular differentiation is a fundamental process in life. All cells in an organism
have the same underlying genotype, but it can be expressed in various phenotypes.
This differential gene expression is the result of highly special regulatory programs.
As enhancers control tissue-specific gene expression (Visel et al. 2009), they could
be crucial regulators of differentiation. Mapping eRNAs with TT-seq along a dif-
ferentiation or trans-differentiation time course could shed light on the differential
use of enhancer elements that govern tissue-specific gene expression. The usage of
H3K4me1 ChIP-seq data and additional data to map open chromatin (DHS, ATAC-
seq) could help to identify primed and active enhancer regions at different stages of
differentiation. TT-seq could establish the link between active enhancer transcrip-
tion and the spatio-temporal pattern of gene expression during cellular differentia-
tion. The timing of events, especially the question if nucleosome rearrangement has
to happen before histone modifications and transcription take place, is of particular
interest.
22.3 Cancer transcriptomics
Enhancer RNAs (eRNAs) play an important role in the regulation of immediate
early genes (IEGs), and therefore they also have an effect on disease and cancer
development (Bahrami et al. 2016). TT-seq can reveal active enhancers in various
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cancer cell lines by mapping transient RNAs. Additionally, the RNA synthesis and
degradation rates of cancer cells can be quantified and compared to healthy control
cells. Therefore, TT-seq can also provide novel and medically relevant insights into
the RNA metabolism of different cancer cell lines.
23 Concluding remarks
TT-seq allows to measure RNA metabolism kinetics on a genome-wide scale in vivo.
The sensitivity of TT-seq to map transient RNAs offers new opportunities to gain
insights in dynamic changes in gene regulatory programs. The application of TT-seq,
together with the proposed normalization strategy, can provide genome-wide rates
of RNA metabolism and reveal global changes in gene expression. The ability of
TT-seq to map only actively transcribed enhancers will provide novel insights into
gene regulation in various biological questions, such as cellular differentiation, cancer
development, or X chromosome inactivation.
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Part VI
Appendix
24 Materials and Methods for Section III
24.1 Spike-in sequences
The following ERCC spike-ins were used to normalize the TT-seq samples (Sec-
tion 8.1).
Spike-in 2
AATACCTTTACAAATGCTTTAACAAGAGGAAATTGTGTTTTTGCCAATTTAAGACCTAATTTAATAGTTAAACCATTAA-
CCTTAGTTGTTCCAAGGCATAATATAGAGAGTGAGATACAGGATGAGCTATTTCAGGGAGTTATTCAGTATGCAGTTG-
CCAAGGCAGTTGCTGATTTAGATTTAGATGAAGATTTAAAGGTTGTTGTCTCTGTTAATGTCCCAGAGGTTCCAATAAC-
CAATTTAAATAAAAGAAAACTCTTCCAATACTTCTATGCCTCAGCAAAGTTAGCTATAAACAGAGCTTTAAATGAATAT-
CCTTCAAAAGAGAAGGTAAAGAAAGAGAAATATAGAGCTTTGCATCCATTAGTTGGATTTAGGGATGTTAGATTGGAG-
TATCCTCCATATCTACAAATTGCTTTGGATGTCCCAACTATGGAGAATTTGGAATTTTTGTTACAAACAATTCCAAATA-
GCGACCACATCATCTTAGAGGCTGGAACACCACTAATTAAAAAGTTTGGTTTAGAGGTTATTGAAATAATGAGAGAAT-
ATTTTGATGGCTTTATTGTTGCTGATTTAAAAACCTTAGACACTGGAAGGGTTGAGGTAAGATTGGCATTTGAAGCAA-
CAGCTAATGCAGTGGCAATAAGTGGAGTAGCACCAAAATCAACAATAATTAAAGCTATCCACGAATGTCAAAAATGTG-
GTTTAATCAGCTATTTGGATATGATGAACGTCTCTGAACCTCAAAAATTATATGATTCATTAAAATTAAAGCCAGATGT-
TGTTATCTTGCATAGAGGGATTGATGAGGAGACATTTGGAATTAAAAAGGAATGGAAATTTAAGGAAAACTGCTTATT-
AGCAATTGCTGGAGGAGTTGGTGTGGAGAATGTTGAAGAGCTTTTAAAAGAATATCAAATATTAATCGTTGGTAGAGC-
AATTACAAAATCAAAAGACCCAGGAAGAGTAATTAGGATTTTATAAACAAGATGGGTTAAAAAAAAAAAAAAAAAAAA-
AAAA
Spike-in 4
TTTCGACGTTTTGAAGGAGGGTTTTAAGTAATGATCGAGATTGAAAAACCAAAAATCGAAACGGTTGAAATCAGCGAC-
GATGCCGAATTTGGTAAGTTTGTCGTAGAGCCACTTGAGCGTGGATATGGTACAACTCTGGGTAACTCCTTACGTCGT-
ATCCTCTTATCCTCACTCCCTGGTGCCGCTGTAACATCAATCCAGATAGATGGTGTACTGCACGAATTCTCGACAATTG-
AAGGCGTTGTGGAAGATGTTACAACGATTATCTTACACATTAAAAAGCTTGCATTGAAAATCTACTCTGATGAAGAGAA-
GACGCTAGAAATTGATGTACAGGGTGAAGGAACTGTAACGGCAGCTGATATTACACACGATAGTGATGTAGAGATCTT-
AAATCCTGATCTTCATATCGCGACTCTTGGTGAGAATGCGAGTTTCCGAGTTCGCCTTACTGCTCAAAGAGGACGTGGG-
TATACGCCTGCTGACGCAAACAAGAGAGGCGATCAGCCAATCGGCGTGATTCCGATCGATTCTATCTATACGCCAGTTT-
CCCGTGTATCTTATCAGGTAGAGAACACTCGTGTAGGCCAAGTTGCAAACTATGATAAACTTACACTTGATGTTTGGAC-
TGATGGAAGCACTGGACCGAAAGAAGCAATTGCGCTTGGTTCAAAGATTTTAACTGAACACCTTAATATATTCGCTGGT-
TTAACTGACGAAGCTCAACATGCTGAAATCATGGTTGAAGAAGAAGAAGATCAAAAAGAGAAAGTTCTTGAAATGACA-
ATTGAAGAATTGGATCTTTCTGTTCGTTCTTACAACTGCTTAAAGCGTGCGGGTATTAACACGGTTCAAGAGCTTGCGA-
ACAAGACGGAAGAAGATATGATGAAAGTTCGAAATCTAGGACGCAAATCACTTGAAGAAGTGAAAGCGAGACTAGAAG-
AACTTGGACTCGGACTTCGCAAAGACGATTGACTAGTTTCCCTTGTGAACTAGGATTTTCCCGGGTACAAAAAAAAAAA-
AAAAAAAAAAA
Spike-in 5
ACTGTCCTTTCATCCATAAGCGGAGAAAGAGGGAATGACATTGTTCTTACACGGCACAAGCAGACAAAATCAACATGGT-
CATTTAGAAATCGGAGGTGTGGATGCTCTCTATTTAGCGGAGAAATATGGTACACCTCTTTACGTATATGATGTGGCTT-
TAATACGTGAGCGTGCTAAAAGCTTTAAGCAGGCGTTTATTTCTGCAGGGCTGAAAGCACAGGTGGCATATGCGAGCA-
AAGCATTCTCATCAGTCGCAATGATTCAGCTCGCTGAGGAAGAGGGACTTTCTTTAGATGTCGTATCCGGAGGAGAGC-
TATATACGGCTGTTGCAGCAGGCTTTCCGGCAGAACGCATCCACTTTCATGGAAACAATAAGAGCAGGGAAGAACTGC-
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GGATGGCGCTTGAGCACCGCATCGGCTGCATTGTGGTGGATAATTTCTATGAAATCGCGCTTCTTGAAGACCTATGTA-
AAGAAACGGGTCACTCCATCGATGTTCTTCTTCGGATCACGCCCGGAGTAGAAGCGCATACGCATGACTACATTACAAC-
GGGCCAGGAAGATTCAAAGTTTGGTTTCGATCTTCATAACGGACAAACTGAACGGGCCATTGAACAAGTATTACAATC-
GGAACACATTCAGCTGCTGGGTGTCCATTGCCATATCGGCTCGCAAATCTTTGATACGGCCGGTTTTGTGTTAGCAGCG-
GAAAAAATCTTCAAAAAACTAGACGAATGGAGAGATTCATATTCATTTGTATCCAAGGTGCTGAATCTTGGAGGAGGT-
TTCGGCATTCGTTATACGGAAGATGATGAACCGCTTCATGCCACTGAATACGTTGAAAAAATTATCGAAGCTGTGAAAG-
AAAATGCTTCCCGTTACGGTTTTGACATTCCGGAAATTTGGATCGAACCGGGCCGTTCTCTCGTGGGAGACGCAGGCA-
CAACTCTTTATACGGTTGGCTCTCAAAAAGAAGTGGATAAGCTGTACAATCGTTTCATCATTCGGCGTGCGAATTAAAA-
AAAAAAAAAAAAAAAAAAAAAA
Spike-in 8
AGATGTATATATGATGTCCTTGGACGGGGTGGCGCAGTATTACTGCAAGAGAGCGGACAGATTAGTGTGTTGGAGCCG-
ACACATCAAAGGTTCGTCCGGGGACCGATCTGCAGCCTACGGGACATTTATCCGTAAAAGCATGGCGCTGTTTCGTACT-
TATCGGAGGCCAGGTATCGTCGCGGCGAGTCTCCCCGACGACGGAGATGGGCGTTACTATCTGGGCCGTCTCGTACTC-
TGTTACTTGGCACAGATGCGAGCCCTCGTAATGTGCATCAGCTAAGGGCGATATTATAATGCGACGTTTGTACGGATT-
CGTTACTAACGTGTTGGACGCTAGTGGAATATGTGTCGTTGGTTAGCCTACCCATGGCTTTCGCGGCGACACATGCTTA-
GACTCTTTCAAAACTTCGGTGAAGTTCACTCAAGCCGCGGAGCGCCGTCGTAATTCACTAGGGATGGCGGTACCCGTG-
CCCGTCCGATTCGTAGCAACCTGCATCACGATTTTGTCTTCGGGCGACTTATCAGATACGGTAATGTAAATACCTGGCA-
TTTGGGCACTTCTTGCGTTTAAGCGGGAAAGATCGCGAGGGCCCGCTATTTGCGATACTTCCCATGTCGGTGCCGTCG-
CCTCTATGTACTCGGAGACGTTAATGCAGAGGCTAAGGACAATTTACCATGACTCGGTAATCCGTTCGTCAAGCAGGTA-
GCTCGAGTCTCCCCACGGACACGTAGTGGGTTTGTAACGATCGATACCGAGTCTTTTTGTCTAGTAGAACCAACCAACC-
ATTAAGGAGTTCACTAGCACATCTTTGCGACCCGATCGTCCGTGTGTCGCGTAATACTTTTGTTATGACGAGACATACG-
CTCAAGCCCTGGGTAGCTAGTCGCGGAGGCACGTTACCGCGCACAACCCCTATTCGTTTACATGTACATCGCATCTGAG-
GTAGTACACTTCCGGCGTACGTGAGTATTTGCGCGTAATAAGCGCGTGTTTAGCTGATCCCCTCTCGTATCGAGGTTAA-
GGCAGATTAGTGCCCAGTAATTGCGTTTTTTTGTCGTTGTCGCAGAACGCGATTTGCTCCGAAAGCTTTAAGCCGTGG-
AAAAAAAAAAAAAAAAAAAAAAAA
Spike-in 9
TCCAGATTACTTCCATTTCCGCCCAAGCTGCTCACAGTATACGGGCGTCGGCATCCAGACCGTCGGCTGATCGTGGTTT-
TACTAGGCTAGACTAGCGTACGAGCACTATGGTCAGTAATTCCTGGAGGAATAGGTACCAAGAAAAAAACGAACCTTT-
GGGTTCCAGAGCTGTACGGTCGCACTGAACTCGGATAGGTCTCAGAAAAACGAAATATAGGCTTACGGTAGGTCCGAA-
TGGCACAAAGCTTGTTCCGTTAGCTGGCATAAGATTCCATGCCTAGATGTGATACACGTTTCTGGAAACTGCCTCGTCA-
TGCGACTGTTCCCCGGGGTCAGGGCCGCTGGTATTTGCTGTAAAGAGGGGCGTTGAGTCCGTCCGACTTCACTGCCCC-
CTTTCAGCCTTTTGGGTCCTGTATCCCAATTCTCAGAGGTCCCGCCGTACGCTGAGGACCACCTGAAACGGGCATCGTC-
GCTCTTCGTTGTTCGTCGACTTCTAGTGTGGAGACGAATTGCCAGAATTATTAACTGCGCAGTTAGGGCAGCGTCTGA-
GGAAGTTTGCTGCGGTTTCGCCTTGACCGCGGGAAGGAGACATAACGATAGCGACTCTGTCTCAGGGGATCTGCATAT-
GTTTGCAGCATACTTTAGGTGGGCCTTGGCTTCCTTCCGCAGTCAAAACCGCGCAATTATCCCCGTCCTGATTTACTGG-
ACTCGCAACGTGGGTCCATCAGTTGTCCGTATACCAAGACGTCTAAGGGCGGTGTACACCCTTTTGAGCAATGATTGCA-
CAACCTGCGATCACCTTATACAGAATTATCAATCAAGCTCCCCGAGGAGCGGACTTGTAAGGACCGCCGCTTTCGCTCG-
GGTCTGCGGGTTATAGCTTTTCAGTCTCGACGGGCTAGCACACATCTGGTTGACTAGGCGCATAGTCGCCATTCACAG-
ATTTGCTCGGCAATCAGTACTGGTAGGCGTTAGACCCCGTGACTCGTGGCTGAACGGCCGTACAACTCGACAGCCGGT-
GCTTGCGTTTTACCCTTAAAAAAAAAAAAAAAAAAAAAAAA
Spike-in 12
TATTGGTGGAGGGGCACAAGTTGCTGAAGTTGCGAGAGGGGCGATAAGTGAGGCAGACAGGCATAATATAAGAGGGG-
AGAGAATTAGCGTAGATACTCTTCCAATAGTTGGTGAAGAAAATTTATATGAGGCTGTTAAAGCTGTAGCAACTCTTCC-
ACGAGTAGGAATTTTAGTTTTAGCTGGCTCTTTAATGGGAGGGAAGATAACTGAAGCAGTTAAAGAATTAAAGGAAAA-
GACTGGCATTCCCGTGATAAGCTTAAAGATGTTTGGCTCTGTTCCTAAGGTTGCTGATTTGGTTGTTGGAGACCCATTG-
CAGGCAGGGGTTTTAGCTGTTATGGCTATTGCTGAAACAGCAAAATTTGATATAAATAAGGTTAAAGGTAGGGTGCTA-
TAAAGATAATTTAATAATTTTTGATGAAACCGAAGCGTTAGCTTTGGGTTATGAAACTCCATGATTTTCATTTAATTTT-
TTCCTATTAATTTTCTCCTAAAAAGTTTCTTTAACATAAATAAGGTTAAAGGGAGAGCTCTATGATTGTCTTCAAAAAT-
ACAAAGATTATTGATGTATATACTGGAGAGGTTGTTAAAGGAAATGTTGCAGTTGAGAGGGATAAAATATCCTTTGTG-
GATTTAAATGATGAAATTGATAAGATAATTGAAAAAATAAAGGAGGATGTTAAAGTTATTGACTTAAAAGGAAAATAT-
TTATCTCCAACATTTATAGATGGGCATATACATATAGAATCTTCCCATCTCATCCCATCAGAGTTTGAGAAATTTGTAT-
TAAAAAGCGGAGTTAGCAAAGTAGTTATAGACCCGCATGAAATAGCAAATATTGCTGGAAAAGAAGGAATTTTGTTTA-
TGTTGAATGATGCCAAAATTTTAGATGTCTATGTTATGCTTCCTTCCTGTGTTCCAGCTACAAACTTAGAAACAAGTGG-
AGCTGAGATTACAGCAGAGAATATTGAAGAACTCATTCTTTAGATAATGTCTTAGGTTAAAAAAAAAAAAAAAAAAAAA-
AAA
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24.2 TT-seq protocol
Jurkat cells were acquired from DSMZ (Braunschweig, Germany). Cells were grown
in RPMI 1640 medium (Gibco) supplemented with 10% heat-inactivated FBS (Gibco)
and 1% Penicillin/Streptomycin (100x, PAA) at 37°C under 5% CO2. Cells were
labeled in media for 5 min with 500 mM 4-thiouridine (4sU, Sigma-Aldrich) and
activated with 50 mM PMA (Sigma-Aldrich) and 1 mM ionomycin (Sigma-Aldrich).
Cells were harvested, spike-ins were added, and RNA was purified and fragmented
as described (Schwalb et al. 2016). Fragmented RNA was subjected to purifica-
tion of labeled RNA as described (Dölken et al. 2008). Labeled fragmented RNA
(TT-seq) and total fragmented RNA (Total RNA-seq) were treated with 2 units
of DNase Turbo (Life Technologies). Sequencing libraries were prepared with the
Ovation Human Blood RNA-seq library kit (NuGEN) following the manufacturer’s
instructions. All samples were sequenced on an Illumina HiSeq 1500 sequencer.
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25 Appendix Figures for Section III
Appendix Figure A1: Correlation of read counts for total RNA-seq libraries. The single scatter
plots show log2 read counts for individual total RNA-seq libraries. The lower triangle displays the
Spearman correlation coefficients for any of the comparisons between two samples.
Appendix Figure A2: Correlation of TT-seq replicate measurements. (A) Correlation of read
counts for TT-seq replicates before T-cell activation. (B) Correlation of read counts TT-seq
replicates 10 min after T-cell activation.
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Appendix Figure A3: Characteristics of non-coding RNA classes. (A) Length distributions
for different non-coding RNA classes (eRNAs, violet; lincRNAs, white; other ncRNAs; grey). The
dashed line shows the distribution of all non-coding RNAs together. (B) Half-life distributions for
different non-coding RNA classes.
−1.0
−0.5
0.0
0.5
1.0
n=327 n=21 n=8240 n=413 n=311 n=44
Pe
ar
so
n 
C
or
re
la
tio
n 
of
 E
xp
re
ss
io
n
ov
er
 T
im
e
distal transcribed enhancer proximal transcribed enhancerclosest transcribed enhancer
mRNA downregulated mRNA unchanged mRNA upregulated
P=6.98e-01
n=351 n=5780 n=287
P=1.51e-02
P=1.84e-02
P=1.34e-05
P=1.35e-01
P=6.13e-06
Appendix Figure A4: Correlation of TT-seq signal over time. Correlation of TT-seq signal over
time between closest (left boxes, dark violet), proximal (middle boxes, medium violet) or distal
(right boxes, light violet) transcribed enhancers and promoters by change in promoter TT-seq
signal (from left to right: downregulated, unchanged, upregulated promoters). Closest transcribed
enhancers were taken for each mRNA irrespective of insulated neighborhood boundaries. Distal and
proximal transcribed enhancers are located in the same insulated neighborhood as their respective
promoters. The Pearson correlation coefficient was calculated between read counts across the
time series (replicates averaged per time point) for each transcribed enhancer-promoter pair. The
P -values were derived by two-sided Mann-Whitney U tests. Box limits are the first and third
quartiles, the band inside the box is the median. The ends of the whiskers extend the box by 1.5
times the interquartile range.
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Appendix Figure A5: Correlation vs Distance. Correlation of TT-seq signal over time between
transcribed enhancers and promoters. Closest transcribed enhancers were taken for each mRNA
irrespective of insulated neighborhood boundaries. The Pearson correlation coefficient was cal-
culated between read counts across the time series (replicates averaged per time point) for each
transcribed enhancer-promoter pair.
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Appendix Figure A6: Correlation of TT-seq signal for closest eRNAs with their mRNAs depen-
dent on location in same insulated neighborhood. The Pearson correlation coefficient was calculated
between read counts across the time series (replicates averaged per time point) for each closest tran-
scribed enhancer- promoter pair. The P -value was derived by a two-sided Mann-Whitney U test.
Box limits are the first and third quartiles, the band inside the box is the median. The ends of the
whiskers extend the box by 1.5 times the interquartile range.
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26 Materials and Methods for Section 20
26.1 4tU-seq
The 4tU-seq experiments and analyses were performed as previously described (Eser
et al. 2016; Miller et al. 2011). The Spt5 depletion strain was grown as described (Shetty
et al. 2017) and cultures were labeled with 4tU for 10 min at 0 and 4.5 hr after the
addition of thiamine and auxin. RNA spike-ins were added to cell pellets at the
first step of RNA purification (Schwalb et al. 2016). The amount of spike-ins was
adjusted to the cell number for each sample (120 ng of spike-in mix for 2.5 ⇥108 cells
for all samples). Sequencing libraries were prepared according to the manufacturer’s
recommendations using the Ovation Universal RNA-Seq System (NuGen). Libraries
were sequenced on an Illumina HiSeq 2500 at LAFUGA, LMU Munich.
26.2 4tU-seq computational analysis
Paired-end 50 base reads with additional 6 base reads of barcodes were obtained
in replicates for all samples. Reads were demultiplexed and mapped with STAR
2.3.0 (Dobin et al. 2015) to the concatenated S. pombe genome and external spike-
in sequences with maximum one mismatch (–outFilterMismatchNmax 2) allowing
for only one mapping position (–outFilterMultimapScoreRange 0). SAM files were
filtered using Samtools (Li et al. 2009; Schwalb et al. 2016) for alignments with
MAPQ of at least 7 (-q 7) and only proper pairs (-f99, -f149, -f84, -f163) were
selected. This resulted in 44-95 million reads per sample. Further data processing
was carried out using the R/Bioconductor environment (Gentleman et al. 2004; R
Development Core Team 2011). Samples were normalized using external spike-ins
as previously described (Schwalb et al. 2016) (Section 8).
26.3 Data availablility
The raw sequencing data reported in this paper have been deposited in the NCBI
Gene Expression Omnibus under accession number GSE85182. Other data have
been deposited to Mendeley Data and are available at http://dx.doi.org/10.
17632/v5jy3367rs.3.
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